data_2ljs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ljs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 45.4 Cg_endo -71.73 130.07 16.44 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.113 1.876 . . . . 0.0 109.562 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -72.29 118.91 15.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.136 0.494 . . . . 0.0 111.381 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 7' ' ' ILE . 14.1 tt -148.52 151.97 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.276 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 16.5 mt -93.39 75.58 4.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.976 0.417 . . . . 0.0 111.852 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 4.6 tmtm? -122.36 122.94 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 9.3 mtpp -65.83 126.2 27.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.962 0.41 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.507 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 7.6 p -100.72 139.9 35.76 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.092 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -104.09 1.37 30.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 165.96 164.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.764 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -58.99 -39.15 80.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.073 0.463 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 t -64.17 -19.27 65.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.393 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.454 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 47.8 t0 -79.84 -18.01 51.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.78 0.8 . . . . 0.0 109.431 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 76.4 m -88.8 143.17 31.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.24 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 145.82 50.33 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.869 2.379 . . . . 0.0 113.198 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.37 -130.19 50.67 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.2 26.11 7.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.5 m -69.34 144.17 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.5 pt -114.4 156.06 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -79.02 105.66 10.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.876 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 57.2 mtpt -67.28 156.32 36.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.26 47.16 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.776 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' A' ' 28' ' ' TYR . 11.4 p-10 -74.89 -6.04 47.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 87.18 29.62 22.07 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.268 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 4.3 m-85 -128.32 156.45 43.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 75.9 m -74.04 127.08 31.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.876 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.931 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.973 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.236 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 61.2 Cg_endo -73.12 -146.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.86 2.373 . . . . 0.0 112.07 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -127.84 100.35 5.9 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.96 0.41 . . . . 0.0 110.037 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.436 HG21 HD11 ' A' ' 7' ' ' ILE . 15.0 tt -151.24 155.58 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.513 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 80.3 mt -118.7 107.98 14.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.096 0.474 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -143.57 126.62 16.41 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.3 mttt -65.67 126.9 29.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.049 0.452 . . . . 0.0 110.508 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.0 p -112.63 145.3 40.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.481 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -99.87 -1.39 37.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.393 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 6.0 ptp85 178.08 164.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.567 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.1 -40.54 94.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.995 0.426 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -65.91 -12.89 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 46.6 t0 -86.23 4.02 40.55 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.007 0.908 . . . . 0.0 109.608 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 97.4 m -111.9 138.76 21.75 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.828 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 145.64 77.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.796 2.331 . . . . 0.0 113.455 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.83 -130.96 50.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.115 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -100.78 19.23 17.53 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.551 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.527 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 99.1 m -65.84 141.36 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -114.12 155.62 15.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.756 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -78.72 100.0 6.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 1.1 ptpm? -71.01 168.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.742 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -48.62 -40.45 24.89 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -81.12 18.64 1.02 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.346 0.573 . . . . 0.0 112.221 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 64.16 35.49 92.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.756 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.738 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.4 m-85 -125.05 157.73 35.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.363 0.601 . . . . 0.0 110.33 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 62.8 m -81.52 116.84 21.49 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.67 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.922 0 CA-C-O 118.24 -1.311 . . . . 0.0 111.021 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 18.6 t . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.52 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.3 Cg_endo -71.37 147.42 52.71 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.724 2.283 . . . . 0.0 110.836 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -59.41 114.12 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.103 0.478 . . . . 0.0 110.987 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -146.02 159.56 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.203 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD22 ' CD2' ' A' ' 28' ' ' TYR . 17.0 mt -128.27 81.55 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 111.021 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.4 125.78 35.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.168 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 7.3 mttm -67.14 117.42 9.15 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.448 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 p -91.06 143.88 26.24 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -106.35 -9.03 16.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.425 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 175.02 163.99 0.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.857 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -60.13 -36.03 76.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.719 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.72 -23.02 67.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.232 0.539 . . . . 0.0 110.675 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -79.41 -19.1 50.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.034 0.921 . . . . 0.0 109.307 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 88.3 m -89.89 140.9 27.82 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.596 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.52 143.03 46.03 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.541 2.161 . . . . 0.0 113.442 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 -131.4 46.55 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.505 -0.771 . . . . 0.0 113.629 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.71 20.01 4.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 84.1 m -73.21 140.01 46.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.543 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.4 pt -112.47 156.53 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.235 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.1 100.21 8.92 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -71.75 153.29 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.199 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.49 -33.66 17.92 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.598 0.561 . . . . 0.0 113.512 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.625 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -61.34 -21.12 63.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.851 0.834 . . . . 0.0 110.184 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 93.95 25.74 16.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.828 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.625 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 5.7 m-85 -129.26 155.71 45.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 89.1 m -72.8 125.28 27.17 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.705 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.17 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.539 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.4 Cg_endo -65.98 142.19 67.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.422 2.081 . . . . 0.0 110.132 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -75.05 63.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.464 0.65 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 7' ' ' ILE . 14.5 tt -98.97 153.85 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.71 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -109.83 107.34 17.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.103 0.477 . . . . 0.0 111.412 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -147.46 125.87 12.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.251 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 14.7 mtpp -67.14 131.46 45.84 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.813 0.339 . . . . 0.0 110.375 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.7 p -109.93 139.59 44.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.125 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 16.5 ptm180 -97.79 -0.83 44.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 177.98 163.95 0.66 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.51 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -46.78 84.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.0 110.571 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 t -64.81 -11.8 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.56 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.423 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 37.8 t0 -82.86 -1.41 51.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.819 0.819 . . . . 0.0 110.14 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.6 m -104.51 141.72 23.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.291 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.76 146.43 48.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.974 2.45 . . . . 0.0 113.596 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -132.39 51.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -96.81 19.7 12.17 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.539 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 85.1 m -69.06 139.23 54.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 pt -118.83 154.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.242 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -76.6 104.46 7.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.7 0.762 . . . . 0.0 110.258 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -78.1 156.3 30.06 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.5 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.93 -32.23 8.65 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.49 0.494 . . . . 0.0 113.931 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.691 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -62.59 -16.65 57.46 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.657 0.741 . . . . 0.0 110.941 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.62 22.27 44.04 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.691 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.5 m-85 -126.57 158.43 36.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.214 0.531 . . . . 0.0 109.779 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.1 m -77.76 120.8 23.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.56 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.443 -1.198 . . . . 0.0 111.781 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 121.13 0.49 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.561 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.0 Cg_endo -77.04 146.89 26.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.815 2.343 . . . . 0.0 110.971 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -61.11 113.91 2.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.83 159.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.652 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.12 82.03 2.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.306 0.574 . . . . 0.0 110.074 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -130.73 128.28 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.664 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.4 mtpt -63.94 124.43 21.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.364 0.415 . . . . 0.0 110.057 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.3 p -96.81 144.88 26.36 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.981 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -106.49 -13.74 15.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.664 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 175.79 165.14 0.36 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -59.02 -38.47 79.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.874 0.369 . . . . 0.0 110.543 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -20.6 66.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.031 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.65 -15.61 48.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 109.673 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 84.6 m -90.48 140.39 26.82 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.557 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 144.41 61.26 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.518 2.145 . . . . 0.0 112.967 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.99 -130.03 50.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.18 16.38 24.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.955 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.8 m -60.45 140.9 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.102 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 pt -111.28 152.63 13.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.165 0.507 . . . . 0.0 111.166 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.1 96.41 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.803 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -79.31 169.11 18.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 112.449 -177.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.07 -35.59 26.31 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 116.3 1.28 . . . . 0.0 116.3 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.5 p-10 -77.7 8.8 4.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.995 0.897 . . . . 0.0 111.81 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.33 25.82 73.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.098 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -124.29 158.63 32.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 110.254 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.5 m -80.75 122.64 27.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.876 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.803 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.955 0 CA-C-O 118.257 -1.302 . . . . 0.0 111.453 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.47 -156.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.898 2.398 . . . . 0.0 111.863 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -94.86 117.53 30.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 7' ' ' ILE . 14.9 tt -150.13 157.83 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.905 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 28' ' ' TYR . 18.3 mt -132.43 70.96 1.46 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.384 0.611 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HE2' ' OD2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -118.39 124.92 48.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.67 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -66.78 119.08 11.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.525 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -94.18 142.92 26.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.792 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -114.01 5.32 16.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 166.96 158.32 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.744 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -58.64 -38.34 77.88 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.217 0.323 . . . . 0.0 111.131 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -63.37 -20.14 65.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.188 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 15.5 t70 -82.53 -12.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.811 0.815 . . . . 0.0 110.19 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 68.1 m -89.98 140.25 27.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.006 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.92 146.31 47.24 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.788 2.325 . . . . 0.0 113.313 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.5 -128.59 47.32 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.305 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -102.99 18.17 22.32 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 72.3 m -65.94 142.71 57.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.8 pt -113.77 155.97 14.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.72 99.52 5.12 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 14.3 mtpp -74.21 151.62 39.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.362 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.03 -25.31 9.88 Favored Glycine 0 C--N 1.339 0.706 0 O-C-N 123.468 0.48 . . . . 0.0 113.25 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.666 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.3 t30 -61.87 -23.45 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.066 0.546 . . . . 0.0 110.752 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.43 53.46 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.3 m-85 -120.36 159.42 25.09 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.404 0.621 . . . . 0.0 110.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 94.5 m -73.95 131.48 41.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.485 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.618 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.882 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.546 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.4 t . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 2.8 Cg_exo -72.3 137.75 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.049 2.499 . . . . 0.0 110.376 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.4 mmt-85 -69.39 118.86 12.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.14 153.89 12.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.423 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.442 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 12.4 mt -97.45 66.96 2.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.954 0.407 . . . . 0.0 111.673 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.528 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.93 122.77 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.429 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -67.35 135.26 52.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -118.75 141.4 48.66 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -100.58 -11.26 20.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.906 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.9 ptp180 176.77 165.21 0.49 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.225 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -59.12 -36.71 75.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.715 0.293 . . . . 0.0 110.871 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -63.36 -24.46 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 110.548 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 33.5 t0 -78.59 -17.96 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.025 0.917 . . . . 0.0 109.972 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 74.7 m -88.4 135.94 32.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.62 143.69 63.37 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.652 2.235 . . . . 0.0 113.328 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.05 -131.75 50.33 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.112 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -93.96 21.13 6.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 90.7 m -72.79 141.01 48.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.338 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.05 152.81 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.998 0.428 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.2 t -80.51 95.3 6.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.847 ' HB3' ' HZ1' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -75.15 156.66 35.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.882 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.55 -28.57 5.04 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.529 0.518 . . . . 0.0 114.216 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.4 t30 -63.07 -16.35 59.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.454 0.645 . . . . 0.0 110.956 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' C ' ' HD1' ' A' ' 28' ' ' TYR . . . 88.8 17.75 55.87 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.675 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.3 m-85 -127.26 158.61 36.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.671 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 91.8 m -78.8 120.39 23.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.015 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.494 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-O 118.508 -1.162 . . . . 0.0 111.952 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 58.7 Cg_endo -71.61 144.63 45.03 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.909 2.406 . . . . 0.0 110.826 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -66.81 102.39 0.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.845 0.355 . . . . 0.0 110.619 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -150.41 154.66 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.824 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.82 111.4 21.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.11 126.12 14.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.2 112.47 5.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.559 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.6 p -87.05 151.47 23.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -127.53 6.38 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 164.78 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.524 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -58.94 -35.41 73.06 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.21 0.319 . . . . 0.0 111.252 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -64.37 -22.65 67.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 111.193 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.76 -12.34 57.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.852 0.834 . . . . 0.0 109.924 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 60.9 m -89.99 137.68 28.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.325 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.87 145.91 76.19 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.846 2.364 . . . . 0.0 112.853 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.29 -126.27 41.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.827 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -108.97 22.23 16.19 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.782 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.673 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 88.2 m -64.76 147.2 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.733 0.301 . . . . 0.0 110.433 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 pt -112.01 153.86 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 0.0 110.771 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.1 t -79.35 95.35 5.69 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 5.8 ptmt -79.89 157.49 26.93 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.501 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.54 4.37 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.713 0.633 . . . . 0.0 114.055 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.641 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 5.2 t30 -62.58 -14.18 39.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.564 0.697 . . . . 0.0 110.891 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.14 75.51 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.641 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.3 m-85 -121.05 167.88 12.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.565 0.698 . . . . 0.0 110.329 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 96.7 m -81.98 127.71 33.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.879 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 CA-C-O 118.22 -1.322 . . . . 0.0 111.432 179.818 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.236 0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.495 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.2 Cg_endo -65.38 153.29 78.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.913 2.409 . . . . 0.0 110.799 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.608 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -77.49 60.85 2.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -96.86 157.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.584 HD22 ' CD2' ' A' ' 28' ' ' TYR . 27.6 mt -123.13 105.06 9.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.21 0.528 . . . . 0.0 110.585 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -147.22 130.27 16.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.2 mttt -60.95 127.96 34.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.568 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 20.3 p -101.9 141.27 35.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -98.48 -17.67 18.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.503 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.9 ptp180 173.15 166.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.822 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -57.31 -39.24 75.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.88 -24.48 67.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.315 0.578 . . . . 0.0 110.683 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 14.8 t70 -81.73 -15.72 53.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.3 m -89.67 141.85 28.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.597 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.12 144.8 53.21 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.584 2.189 . . . . 0.0 113.204 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.73 -131.55 52.11 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.312 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -98.84 21.92 10.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.652 0.263 . . . . 0.0 111.074 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.2 m -67.68 141.36 56.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.29 153.17 14.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.063 0.459 . . . . 0.0 110.602 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.7 t -79.68 96.1 6.13 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.774 ' HB3' ' HZ1' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -81.06 156.76 25.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.077 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.81 -27.25 3.16 Favored Glycine 0 N--CA 1.468 0.799 0 O-C-N 123.713 0.633 . . . . 0.0 114.458 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.71 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 2.2 t30 -62.7 -16.87 59.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.335 0.588 . . . . 0.0 110.878 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 89.34 13.32 61.85 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.71 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.9 m-85 -124.91 160.34 29.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.638 0.733 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 68.5 m -77.88 122.15 25.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.569 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.742 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.923 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.699 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.56 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 64.7 Cg_endo -73.56 161.12 42.92 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 111.26 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.7 mmt-85 -80.0 61.19 3.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.395 0.617 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -94.45 155.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.731 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' CD2' ' A' ' 28' ' ' TYR . 26.7 mt -117.44 105.91 12.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.75 126.37 12.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 48.0 mtpt -63.75 118.94 9.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.7 p -89.17 135.76 33.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.835 0.826 . . . . 0.0 113.174 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.26 -2.17 22.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.294 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 168.64 160.55 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.653 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.11 -41.02 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.84 0.352 . . . . 0.0 110.95 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -64.62 -16.02 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.335 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.19 -17.02 47.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.928 0.871 . . . . 0.0 109.238 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 91.5 m -89.73 140.43 27.98 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.26 146.18 56.38 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.927 2.418 . . . . 0.0 113.366 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.76 -129.09 47.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.288 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -102.17 23.26 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.575 0.226 . . . . 0.0 110.804 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.56 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 91.4 m -68.59 140.7 55.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.68 155.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -77.57 103.35 7.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.811 ' HB3' ' HZ1' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -84.1 170.3 13.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.962 -179.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.83 -34.48 29.75 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 116.333 1.293 . . . . 0.0 116.333 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.4 p-10 -78.47 8.59 4.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.102 0.951 . . . . 0.0 111.888 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.19 26.45 72.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.992 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m-85 -125.64 156.88 38.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 110.374 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.4 m -77.77 120.21 22.36 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.788 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.685 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.438 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.0 t . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.7 Cg_endo -76.17 163.26 33.04 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.719 2.279 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.494 HH22 HD23 ' A' ' 8' ' ' LEU . 37.8 tpt85 -74.26 66.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.341 0.591 . . . . 0.0 110.713 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -88.86 156.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.494 HD23 HH22 ' A' ' 6' ' ' ARG . 10.9 mt -121.72 64.56 0.9 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.38 124.63 52.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.526 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.93 122.59 17.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 12.9 p -96.94 138.98 33.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 15.1 ptm180 -110.28 -1.34 17.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.16 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' HG2' ' HG3' ' A' ' 12' ' ' ARG . 16.8 ptm180 172.63 157.47 0.1 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.009 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -58.2 -39.02 77.9 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 123.458 0.473 . . . . 0.0 111.085 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -62.73 -20.57 65.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.497 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.495 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 44.7 t0 -80.99 -15.29 56.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.932 0.872 . . . . 0.0 109.728 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 87.4 m -89.94 139.81 27.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.016 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.42 146.23 39.41 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.839 2.359 . . . . 0.0 113.476 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.01 -129.97 48.7 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.464 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -98.7 19.07 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.74 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.5 m -67.21 137.63 56.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.158 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 pt -115.83 156.14 16.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -77.03 100.96 5.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.692 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -80.23 153.85 28.28 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.338 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.25 3.96 Favored Glycine 0 N--CA 1.468 0.781 0 O-C-N 123.546 0.529 . . . . 0.0 114.108 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.615 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.9 t30 -61.39 -20.23 62.8 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.887 0.475 . . . . 0.0 111.043 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.79 9.06 57.76 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.85 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.615 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.2 m-85 -123.95 163.45 21.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.565 0.698 . . . . 0.0 110.401 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 93.6 m -75.72 127.55 33.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.692 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.951 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.035 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 51.9 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 83.5 Cg_endo -81.94 -151.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.901 2.401 . . . . 0.0 112.431 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 30.6 tpt180 -94.61 113.4 25.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 7' ' ' ILE . 14.8 tt -150.64 156.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.479 HD22 ' CD2' ' A' ' 28' ' ' TYR . 14.8 mt -133.1 68.52 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.463 0.649 . . . . 0.0 110.745 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.38 125.24 52.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -64.11 118.32 8.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.41 136.21 33.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.028 0.918 . . . . 0.0 113.383 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -106.08 -6.12 18.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.336 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 167.03 158.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.74 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.55 -43.78 72.3 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.44 0.463 . . . . 0.0 111.166 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 m -63.0 -20.67 65.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.999 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -83.78 -10.29 58.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.848 0.832 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.4 m -92.38 143.55 27.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 143.55 43.95 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.617 2.211 . . . . 0.0 113.278 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.32 -128.55 47.5 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.605 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -96.9 10.0 40.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.326 0.108 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.3 m -62.65 138.64 58.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 110.364 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.43 163.84 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.817 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.29 98.39 8.12 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.689 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -79.48 153.95 29.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.384 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.67 -28.12 4.98 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 123.537 0.523 . . . . 0.0 114.106 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 2.0 t30 -61.13 -20.24 62.44 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.929 0.492 . . . . 0.0 111.207 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.7 9.37 57.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.827 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.608 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.4 m-85 -123.1 165.61 16.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.511 0.672 . . . . 0.0 110.331 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -77.6 128.63 34.45 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.065 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.689 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.11 0 CA-C-O 118.171 -1.349 . . . . 0.0 111.143 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.5 Cg_endo -71.57 152.67 59.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.681 2.254 . . . . 0.0 111.39 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -73.92 65.47 1.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.413 0.625 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 8' ' ' LEU . 10.2 tp -105.76 165.79 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.864 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 28' ' ' TYR . 54.2 mt -128.35 105.08 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.223 0.535 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.3 tmtm? -147.09 129.57 15.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.911 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -68.01 130.74 43.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.599 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 7.5 p -110.25 149.03 30.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.583 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -113.04 2.28 15.66 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 170.5 162.52 0.07 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.776 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.38 -35.31 71.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.884 0.373 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -62.21 -25.46 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.078 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 51.8 t0 -76.72 -18.97 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.799 0.809 . . . . 0.0 109.492 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 92.6 m -88.89 138.07 29.54 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.843 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 146.65 41.3 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.855 2.37 . . . . 0.0 113.259 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.28 -130.4 48.81 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.334 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.52 18.13 18.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.796 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.16 139.04 58.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -113.2 154.63 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.276 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -78.74 98.95 6.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -75.95 155.52 35.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.389 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.17 -30.95 5.82 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 123.546 0.529 . . . . 0.0 114.102 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.659 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.6 t30 -61.54 -17.77 56.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.437 0.637 . . . . 0.0 111.122 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.64 13.11 58.65 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.852 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.659 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.8 m-85 -120.11 162.58 19.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.162 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.9 m -80.13 125.31 29.66 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.31 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.5 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.44 -1.083 0 CA-C-O 118.283 -1.287 . . . . 0.0 111.017 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.76 153.8 59.07 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.947 2.431 . . . . 0.0 110.772 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.475 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -70.32 114.17 8.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.098 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 tt -150.17 156.92 6.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.386 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.48 HD23 ' CD2' ' A' ' 28' ' ' TYR . 34.8 mt -122.4 83.73 2.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.443 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -129.51 126.13 37.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.0 mtpm? -64.41 124.26 21.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.6 p -92.99 142.93 26.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.016 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -106.0 -8.61 17.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 175.57 165.69 0.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.406 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -61.29 -42.41 98.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -68.87 -5.67 22.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.8 -13.41 31.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.733 . . . . 0.0 109.22 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 90.7 m -89.9 143.6 30.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.995 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.98 145.6 80.18 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.749 2.299 . . . . 0.0 112.824 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.57 -126.67 42.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.991 -0.624 . . . . 0.0 111.948 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.13 22.45 15.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.697 0.284 . . . . 0.0 110.541 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.4 m -65.13 150.57 47.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.123 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 22' ' ' ILE . 37.9 pt -116.88 158.26 17.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 111.51 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 t -82.36 97.31 8.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.581 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -71.19 153.22 42.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.345 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.97 -32.37 6.15 Favored Glycine 0 N--CA 1.468 0.831 0 O-C-N 123.547 0.529 . . . . 0.0 114.129 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.617 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -61.39 -19.45 61.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.402 0.62 . . . . 0.0 110.992 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 18.87 36.06 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.022 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.7 m-85 -123.8 161.42 25.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.261 0.553 . . . . 0.0 110.007 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 64.5 m -80.65 125.23 29.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.066 0 CA-C-O 118.36 -1.244 . . . . 0.0 111.156 179.432 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 45.7 t . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.75 -145.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.762 2.308 . . . . 0.0 111.673 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -110.99 118.35 35.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.52 154.91 8.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.3 mt -117.47 64.45 0.73 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.148 0.499 . . . . 0.0 111.288 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -110.24 121.54 45.51 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 111.34 4.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.5 p -87.34 150.7 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -122.66 1.9 9.48 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 166.38 158.1 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.73 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.67 -39.02 73.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.492 0.495 . . . . 0.0 111.202 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -61.77 -23.08 65.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.345 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.48 -9.46 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.833 0.825 . . . . 0.0 109.906 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.9 m -93.41 142.67 25.53 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.03 144.05 80.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.803 2.335 . . . . 0.0 112.682 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.86 -125.25 38.55 Favored Glycine 0 CA--C 1.509 -0.327 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.44 26.5 10.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.884 0.374 . . . . 0.0 110.054 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.6 m -63.57 148.11 49.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.775 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 30' ' ' GLY . 23.0 pt -112.18 155.45 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.308 0.575 . . . . 0.0 111.71 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.34 97.51 7.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -80.0 158.01 26.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.923 -178.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.93 3.88 Favored Glycine 0 N--CA 1.468 0.812 0 O-C-N 123.546 0.529 . . . . 0.0 114.003 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.642 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 6.2 t30 -62.41 -14.76 44.02 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.441 0.638 . . . . 0.0 110.964 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.14 74.96 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.642 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.2 m-85 -122.83 166.76 14.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.387 0.613 . . . . 0.0 110.129 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 92.6 m -78.48 126.94 31.46 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.0 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 22' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-O 118.256 -1.302 . . . . 0.0 110.98 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 1.6 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.767 0.318 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.577 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 49.5 Cg_endo -68.44 137.55 39.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.711 2.274 . . . . 0.0 110.161 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.692 ' NH1' ' HA2' ' A' ' 30' ' ' GLY . 1.2 tpp180 -76.25 119.57 20.34 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.429 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -149.77 151.79 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.985 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 28' ' ' TYR . 12.5 mt -100.67 72.88 1.57 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 3.1 tmtm? -118.58 127.48 53.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.737 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.82 123.29 19.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.537 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . 28.4 p -102.28 146.04 28.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.958 0.885 . . . . 0.0 113.303 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' A' ' 12' ' ' ARG . 4.5 mmp_? -114.46 -9.72 12.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.068 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 7.0 ptp85 178.64 161.07 0.65 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.1 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 -39.54 81.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.812 0.339 . . . . 0.0 110.804 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 11' ' ' CYS . 3.5 t70 -84.89 -15.81 43.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.812 0.815 . . . . 0.0 109.285 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 40.1 m -87.8 144.39 34.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.378 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.93 143.27 59.96 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.484 2.123 . . . . 0.0 112.834 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.21 -126.57 42.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.859 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -107.17 27.62 8.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.782 0.325 . . . . 0.0 111.043 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.577 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 56.2 m -70.13 148.13 49.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 22' ' ' ILE . 39.1 pt -112.61 152.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.0 110.902 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -81.84 102.0 10.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.168 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 6.5 ptmt -87.78 158.89 18.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.651 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.34 -26.71 3.59 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.8 0.688 . . . . 0.0 114.058 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.638 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 7.5 t30 -61.17 -17.04 50.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.446 0.641 . . . . 0.0 110.807 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.71 69.2 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.638 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.1 m-85 -126.09 165.83 18.12 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.664 0.745 . . . . 0.0 110.385 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 98.9 m -78.43 122.85 26.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.841 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.692 ' HA2' ' NH1' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.44 -1.097 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.962 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.6 t . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.688 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.6 Cg_endo -70.39 154.96 64.81 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.126 2.55 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -66.17 96.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.491 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 7' ' ' ILE . 14.5 tt -150.49 153.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.954 0.407 . . . . 0.0 110.49 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -146.39 130.98 17.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -61.22 128.04 34.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.989 0.423 . . . . 0.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.5 p -92.65 142.58 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.504 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -107.13 -14.75 14.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.469 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 174.97 161.35 0.21 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.479 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -56.06 -45.64 79.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.004 0.431 . . . . 0.0 111.074 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.6 t -65.65 -17.07 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.449 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -13.69 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.656 0.741 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.0 m -88.66 143.59 32.16 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 144.33 58.21 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.797 2.331 . . . . 0.0 113.32 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.56 -128.96 48.05 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -101.23 17.5 22.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.501 0.191 . . . . 0.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.688 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 87.3 m -67.25 140.86 57.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -115.61 159.18 15.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.59 97.02 5.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.754 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 5.7 ptmt -77.31 156.34 31.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.957 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.24 -30.83 5.91 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 123.53 0.519 . . . . 0.0 114.142 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.653 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.9 t30 -62.01 -16.59 52.74 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.604 0.716 . . . . 0.0 110.963 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.88 22.42 46.02 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-85 -128.67 164.1 23.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.5 m -79.99 125.22 29.49 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.806 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.542 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.662 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.626 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.3 Cg_endo -71.31 146.11 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.685 2.257 . . . . 0.0 111.196 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -66.44 101.42 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.943 0.401 . . . . 0.0 110.772 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.42 152.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.45 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.12 108.1 16.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.565 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.8 tmtm? -146.06 129.69 17.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.483 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.06 131.77 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -117.26 139.81 50.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.356 0.598 . . . . 0.0 111.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -101.94 0.2 34.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 177.66 163.02 0.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.909 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -60.27 -38.04 82.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.736 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -63.72 -18.78 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.01 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.565 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 50.8 t0 -78.87 -18.52 53.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.0 m -88.44 140.96 30.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.345 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.29 145.77 30.87 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.751 2.301 . . . . 0.0 113.444 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.23 -130.5 49.03 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.52 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -97.62 16.13 21.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.994 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.3 139.72 58.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.93 154.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.887 0.375 . . . . 0.0 110.269 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -80.55 99.68 8.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -76.51 154.54 34.53 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.314 -179.378 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.58 -27.65 4.52 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 123.537 0.523 . . . . 0.0 114.14 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.646 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.8 t30 -62.33 -18.28 61.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.81 9.0 60.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.761 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-85 -121.27 163.14 19.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.562 0.696 . . . . 0.0 110.732 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 68.4 m -78.02 126.06 30.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.387 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.55 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.92 0 CA-C-O 118.272 -1.294 . . . . 0.0 111.161 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.407 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 49.4 t . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.613 0.244 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 48.9 Cg_endo -68.39 163.42 36.57 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.682 2.254 . . . . 0.0 111.229 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -75.54 63.61 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.189 0.519 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.85 155.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 73.12 1.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.247 0.546 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HZ2' ' CG ' ' A' ' 16' ' ' ASP . 12.4 tmtt? -122.35 126.1 47.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.361 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.5 mtpm? -62.66 126.62 27.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.046 0.451 . . . . 0.0 110.35 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 8.4 p -95.47 141.53 28.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.169 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.65 -13.86 22.52 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.2 ptp180 170.54 164.87 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.452 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.79 -41.11 77.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.741 0.305 . . . . 0.0 111.159 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -64.36 -21.79 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.187 0.518 . . . . 0.0 111.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 16.0 t70 -82.14 -13.34 57.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.76 0.79 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.3 m -89.54 140.8 28.32 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.0 143.1 64.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.874 2.383 . . . . 0.0 113.25 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.25 -131.54 42.0 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 113.725 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -93.32 24.86 3.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 94.9 m -77.99 143.35 37.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 pt -114.16 160.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.837 0.351 . . . . 0.0 110.482 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 t -83.06 97.8 8.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.686 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 2.8 ptmm? -74.68 166.6 23.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.213 0.53 . . . . 0.0 112.266 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.45 -37.67 26.15 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.178 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.686 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -79.52 16.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.761 0.78 . . . . 0.0 112.022 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 63.33 32.99 86.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.896 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.6 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -126.48 162.63 25.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 58.3 m -82.08 121.85 27.09 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.107 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.035 -1.425 . . . . 0.0 111.149 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 93.9 Cg_endo -80.05 -149.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.789 2.326 . . . . 0.0 111.958 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.429 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 18.3 tpp85 -90.45 102.63 15.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.25 154.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.577 HD22 ' CD2' ' A' ' 28' ' ' TYR . 37.2 mt -135.67 104.5 5.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.66 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.35 125.25 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.6 mtpt -66.43 119.11 11.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.619 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -97.22 135.84 38.58 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 13.6 ptm180 -102.4 6.46 40.23 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 165.76 157.79 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.49 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.73 -33.28 72.66 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.242 0.339 . . . . 0.0 110.929 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 42.2 t0 -82.17 -9.53 59.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.779 0.799 . . . . 0.0 110.069 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 93.5 m -89.97 137.97 27.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.317 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.56 144.99 46.11 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.852 2.368 . . . . 0.0 113.261 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.86 -131.36 47.54 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.419 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.5 22.37 6.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 72.7 m -76.67 142.82 40.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.443 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -113.82 159.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.76 97.34 8.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.585 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 3.0 ptpt -75.48 153.01 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.757 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.2 -28.88 4.6 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 123.665 0.603 . . . . 0.0 114.198 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.657 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -61.41 -21.15 63.83 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.164 0.507 . . . . 0.0 111.151 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 98.28 9.96 52.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.71 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.4 m-85 -122.0 157.76 30.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.703 0.764 . . . . 0.0 110.871 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 72.7 m -77.74 126.64 31.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.469 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.461 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 23.6 mmt85 -80.71 154.21 27.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.36 135.75 55.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 t -159.89 131.11 3.87 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 45.4 Cg_endo -71.73 130.07 16.44 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.113 1.876 . . . . 0.0 109.562 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -72.29 118.91 15.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.136 0.494 . . . . 0.0 111.381 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 7' ' ' ILE . 14.1 tt -148.52 151.97 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.276 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 16.5 mt -93.39 75.58 4.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.976 0.417 . . . . 0.0 111.852 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 4.6 tmtm? -122.36 122.94 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 9.3 mtpp -65.83 126.2 27.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.962 0.41 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.507 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 7.6 p -100.72 139.9 35.76 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.092 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -104.09 1.37 30.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 165.96 164.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.764 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -58.99 -39.15 80.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.073 0.463 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 t -64.17 -19.27 65.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.393 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.454 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 47.8 t0 -79.84 -18.01 51.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.78 0.8 . . . . 0.0 109.431 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 76.4 m -88.8 143.17 31.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.24 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 145.82 50.33 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.869 2.379 . . . . 0.0 113.198 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.37 -130.19 50.67 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 36.9 mt-10 -101.2 26.11 7.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.5 m -69.34 144.17 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.5 pt -114.4 156.06 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -79.02 105.66 10.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.876 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 57.2 mtpt -67.28 156.32 36.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.26 47.16 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.776 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' A' ' 28' ' ' TYR . 11.4 p-10 -74.89 -6.04 47.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 87.18 29.62 22.07 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.268 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 4.3 m-85 -128.32 156.45 43.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 75.9 m -74.04 127.08 31.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.876 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.931 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.973 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.542 ' HG3' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.2 128.02 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.221 -179.248 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.63 133.52 35.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.989 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.3 t -157.1 134.43 6.82 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.998 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 61.2 Cg_endo -73.12 -146.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.86 2.373 . . . . 0.0 112.07 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -127.84 100.35 5.9 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.96 0.41 . . . . 0.0 110.037 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 HG21 HD11 ' A' ' 7' ' ' ILE . 15.0 tt -151.24 155.58 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.513 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 80.3 mt -118.7 107.98 14.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.096 0.474 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -143.57 126.62 16.41 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.3 mttt -65.67 126.9 29.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.049 0.452 . . . . 0.0 110.508 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.0 p -112.63 145.3 40.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.481 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -99.87 -1.39 37.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.393 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 6.0 ptp85 178.08 164.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.567 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.1 -40.54 94.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.995 0.426 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -65.91 -12.89 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 46.6 t0 -86.23 4.02 40.55 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.007 0.908 . . . . 0.0 109.608 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 97.4 m -111.9 138.76 21.75 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.828 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 145.64 77.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.796 2.331 . . . . 0.0 113.455 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.83 -130.96 50.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.115 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 54.3 mt-10 -100.78 19.23 17.53 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.551 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.527 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 99.1 m -65.84 141.36 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -114.12 155.62 15.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.756 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -78.72 100.0 6.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 1.1 ptpm? -71.01 168.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.742 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -48.62 -40.45 24.89 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -81.12 18.64 1.02 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.346 0.573 . . . . 0.0 112.221 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 64.16 35.49 92.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.756 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.738 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.4 m-85 -125.05 157.73 35.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.363 0.601 . . . . 0.0 110.33 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 62.8 m -81.52 116.84 21.49 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.67 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.922 0 CA-C-O 118.24 -1.311 . . . . 0.0 111.021 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.961 0.41 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.861 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 61.7 mtm180 -74.9 138.64 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.481 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.63 138.78 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 18.6 t -144.59 134.53 11.73 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.52 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.3 Cg_endo -71.37 147.42 52.71 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.724 2.283 . . . . 0.0 110.836 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -59.41 114.12 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.103 0.478 . . . . 0.0 110.987 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -146.02 159.56 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.203 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD22 ' CD2' ' A' ' 28' ' ' TYR . 17.0 mt -128.27 81.55 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 111.021 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.4 125.78 35.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.168 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 7.3 mttm -67.14 117.42 9.15 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.448 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 p -91.06 143.88 26.24 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -106.35 -9.03 16.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.425 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 175.02 163.99 0.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.857 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -60.13 -36.03 76.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.719 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.72 -23.02 67.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.232 0.539 . . . . 0.0 110.675 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -79.41 -19.1 50.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.034 0.921 . . . . 0.0 109.307 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 88.3 m -89.89 140.9 27.82 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.596 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.52 143.03 46.03 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.541 2.161 . . . . 0.0 113.442 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 -131.4 46.55 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.505 -0.771 . . . . 0.0 113.629 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.861 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 5.7 mm-40 -89.71 20.01 4.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 84.1 m -73.21 140.01 46.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.543 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.642 HG21 HH21 ' A' ' 2' ' ' ARG . 37.4 pt -112.47 156.53 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.235 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.1 100.21 8.92 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -71.75 153.29 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.199 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.49 -33.66 17.92 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.598 0.561 . . . . 0.0 113.512 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.625 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -61.34 -21.12 63.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.851 0.834 . . . . 0.0 110.184 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 93.95 25.74 16.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.828 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.625 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 5.7 m-85 -129.26 155.71 45.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 89.1 m -72.8 125.28 27.17 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.705 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.17 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.915 0.388 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -96.05 157.93 15.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.138 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.99 133.02 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.637 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 t -164.99 132.38 2.38 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.233 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.539 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.4 Cg_endo -65.98 142.19 67.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.422 2.081 . . . . 0.0 110.132 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -75.05 63.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.464 0.65 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 7' ' ' ILE . 14.5 tt -98.97 153.85 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.71 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -109.83 107.34 17.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.103 0.477 . . . . 0.0 111.412 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -147.46 125.87 12.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.251 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 14.7 mtpp -67.14 131.46 45.84 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.813 0.339 . . . . 0.0 110.375 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.7 p -109.93 139.59 44.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.125 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 16.5 ptm180 -97.79 -0.83 44.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 177.98 163.95 0.66 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.51 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -46.78 84.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.0 110.571 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 t -64.81 -11.8 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.56 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.423 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 37.8 t0 -82.86 -1.41 51.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.819 0.819 . . . . 0.0 110.14 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.6 m -104.51 141.72 23.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.291 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.76 146.43 48.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.974 2.45 . . . . 0.0 113.596 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -132.39 51.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -96.81 19.7 12.17 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.539 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 85.1 m -69.06 139.23 54.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 pt -118.83 154.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.242 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -76.6 104.46 7.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.7 0.762 . . . . 0.0 110.258 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -78.1 156.3 30.06 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.5 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.93 -32.23 8.65 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.49 0.494 . . . . 0.0 113.931 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.691 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -62.59 -16.65 57.46 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.657 0.741 . . . . 0.0 110.941 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.62 22.27 44.04 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.691 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.5 m-85 -126.57 158.43 36.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.214 0.531 . . . . 0.0 109.779 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.1 m -77.76 120.8 23.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.56 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.443 -1.198 . . . . 0.0 111.781 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.849 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 99.7 mtt180 -64.06 140.25 58.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.784 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -80.59 134.54 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.373 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 t -153.49 128.66 4.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.13 0.49 . . . . 0.0 111.203 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.561 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.0 Cg_endo -77.04 146.89 26.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.815 2.343 . . . . 0.0 110.971 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -61.11 113.91 2.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.83 159.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.652 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.12 82.03 2.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.306 0.574 . . . . 0.0 110.074 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -130.73 128.28 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.664 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.4 mtpt -63.94 124.43 21.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.364 0.415 . . . . 0.0 110.057 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.3 p -96.81 144.88 26.36 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.981 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -106.49 -13.74 15.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.664 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 175.79 165.14 0.36 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -59.02 -38.47 79.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.874 0.369 . . . . 0.0 110.543 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -20.6 66.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.031 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.65 -15.61 48.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 109.673 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 84.6 m -90.48 140.39 26.82 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.557 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 144.41 61.26 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.518 2.145 . . . . 0.0 112.967 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.99 -130.03 50.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 53.8 mt-10 -100.18 16.38 24.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.955 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.8 m -60.45 140.9 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.102 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.461 HG21 HH11 ' A' ' 2' ' ' ARG . 35.7 pt -111.28 152.63 13.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.165 0.507 . . . . 0.0 111.166 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.1 96.41 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.803 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -79.31 169.11 18.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 112.449 -177.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.07 -35.59 26.31 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 116.3 1.28 . . . . 0.0 116.3 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.5 p-10 -77.7 8.8 4.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.995 0.897 . . . . 0.0 111.81 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.33 25.82 73.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.098 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -124.29 158.63 32.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 110.254 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.5 m -80.75 122.64 27.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.876 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.803 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.955 0 CA-C-O 118.257 -1.302 . . . . 0.0 111.453 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 13.2 mmp_? -66.66 134.76 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.5 136.09 40.93 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.004 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -154.08 131.82 6.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.023 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.47 -156.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.898 2.398 . . . . 0.0 111.863 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -94.86 117.53 30.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 7' ' ' ILE . 14.9 tt -150.13 157.83 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.905 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 28' ' ' TYR . 18.3 mt -132.43 70.96 1.46 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.384 0.611 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HE2' ' OD2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -118.39 124.92 48.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.67 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -66.78 119.08 11.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.525 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -94.18 142.92 26.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.792 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -114.01 5.32 16.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 166.96 158.32 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.744 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -58.64 -38.34 77.88 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.217 0.323 . . . . 0.0 111.131 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -63.37 -20.14 65.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.188 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 15.5 t70 -82.53 -12.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.811 0.815 . . . . 0.0 110.19 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 68.1 m -89.98 140.25 27.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.006 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.92 146.31 47.24 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.788 2.325 . . . . 0.0 113.313 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.5 -128.59 47.32 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.305 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 54.4 mt-10 -102.99 18.17 22.32 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.774 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 72.3 m -65.94 142.71 57.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.8 pt -113.77 155.97 14.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.72 99.52 5.12 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 14.3 mtpp -74.21 151.62 39.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.362 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.03 -25.31 9.88 Favored Glycine 0 C--N 1.339 0.706 0 O-C-N 123.468 0.48 . . . . 0.0 113.25 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.666 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.3 t30 -61.87 -23.45 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.066 0.546 . . . . 0.0 110.752 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.43 53.46 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.3 m-85 -120.36 159.42 25.09 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.404 0.621 . . . . 0.0 110.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 94.5 m -73.95 131.48 41.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.485 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.618 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.882 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.546 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . 0.447 ' HB2' ' H ' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.45 0.166 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.766 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 76.1 mtp180 -70.9 135.49 48.01 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.31 133.44 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.4 t -159.63 137.15 7.09 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 120.924 0.392 . . . . 0.0 111.955 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 2.8 Cg_exo -72.3 137.75 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.049 2.499 . . . . 0.0 110.376 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.4 mmt-85 -69.39 118.86 12.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.14 153.89 12.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.423 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 12.4 mt -97.45 66.96 2.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.954 0.407 . . . . 0.0 111.673 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.528 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.93 122.77 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.429 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -67.35 135.26 52.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -118.75 141.4 48.66 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -100.58 -11.26 20.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.906 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.9 ptp180 176.77 165.21 0.49 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.225 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -59.12 -36.71 75.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.715 0.293 . . . . 0.0 110.871 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -63.36 -24.46 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 110.548 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 33.5 t0 -78.59 -17.96 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.025 0.917 . . . . 0.0 109.972 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 74.7 m -88.4 135.94 32.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.62 143.69 63.37 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.652 2.235 . . . . 0.0 113.328 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.05 -131.75 50.33 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.112 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.766 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 46.8 mm-40 -93.96 21.13 6.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 90.7 m -72.79 141.01 48.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.338 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.05 152.81 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.998 0.428 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.2 t -80.51 95.3 6.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.847 ' HB3' ' HZ1' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -75.15 156.66 35.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.882 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.55 -28.57 5.04 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.529 0.518 . . . . 0.0 114.216 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.4 t30 -63.07 -16.35 59.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.454 0.645 . . . . 0.0 110.956 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' C ' ' HD1' ' A' ' 28' ' ' TYR . . . 88.8 17.75 55.87 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.675 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.3 m-85 -127.26 158.61 36.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.671 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 91.8 m -78.8 120.39 23.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.015 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.494 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-O 118.508 -1.162 . . . . 0.0 111.952 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 121.333 0.587 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . 56.5 mtm-85 -82.73 -177.53 6.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.711 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -71.53 136.61 47.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.974 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -148.47 124.3 5.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 120.997 0.427 . . . . 0.0 111.549 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 58.7 Cg_endo -71.61 144.63 45.03 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.909 2.406 . . . . 0.0 110.826 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -66.81 102.39 0.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.845 0.355 . . . . 0.0 110.619 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -150.41 154.66 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.824 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.82 111.4 21.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.11 126.12 14.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.2 112.47 5.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.559 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.6 p -87.05 151.47 23.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -127.53 6.38 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 164.78 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.524 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -58.94 -35.41 73.06 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.21 0.319 . . . . 0.0 111.252 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -64.37 -22.65 67.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 111.193 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.76 -12.34 57.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.852 0.834 . . . . 0.0 109.924 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 60.9 m -89.99 137.68 28.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.325 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.87 145.91 76.19 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.846 2.364 . . . . 0.0 112.853 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.29 -126.27 41.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.827 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 52.4 mt-10 -108.97 22.23 16.19 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.782 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.673 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 88.2 m -64.76 147.2 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.733 0.301 . . . . 0.0 110.433 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.499 HG23 HH22 ' A' ' 2' ' ' ARG . 37.0 pt -112.01 153.86 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 0.0 110.771 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.1 t -79.35 95.35 5.69 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 5.8 ptmt -79.89 157.49 26.93 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.501 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.54 4.37 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.713 0.633 . . . . 0.0 114.055 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.641 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 5.2 t30 -62.58 -14.18 39.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.564 0.697 . . . . 0.0 110.891 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.14 75.51 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.641 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.3 m-85 -121.05 167.88 12.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.565 0.698 . . . . 0.0 110.329 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 96.7 m -81.98 127.71 33.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.879 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 CA-C-O 118.22 -1.322 . . . . 0.0 111.432 179.818 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.731 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 62.9 mtm180 -78.59 155.03 29.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.434 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.42 134.53 50.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 0.0 110.642 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -160.88 131.02 3.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.167 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.495 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.2 Cg_endo -65.38 153.29 78.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.913 2.409 . . . . 0.0 110.799 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.608 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -77.49 60.85 2.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -96.86 157.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.584 HD22 ' CD2' ' A' ' 28' ' ' TYR . 27.6 mt -123.13 105.06 9.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.21 0.528 . . . . 0.0 110.585 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -147.22 130.27 16.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.2 mttt -60.95 127.96 34.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.568 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 20.3 p -101.9 141.27 35.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -98.48 -17.67 18.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.503 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.9 ptp180 173.15 166.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.822 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -57.31 -39.24 75.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.88 -24.48 67.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.315 0.578 . . . . 0.0 110.683 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 14.8 t70 -81.73 -15.72 53.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.3 m -89.67 141.85 28.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.597 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.12 144.8 53.21 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.584 2.189 . . . . 0.0 113.204 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.73 -131.55 52.11 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.312 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.731 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 31.6 mt-10 -98.84 21.92 10.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.652 0.263 . . . . 0.0 111.074 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.2 m -67.68 141.36 56.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.29 153.17 14.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.063 0.459 . . . . 0.0 110.602 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.7 t -79.68 96.1 6.13 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.774 ' HB3' ' HZ1' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -81.06 156.76 25.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.077 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.81 -27.25 3.16 Favored Glycine 0 N--CA 1.468 0.799 0 O-C-N 123.713 0.633 . . . . 0.0 114.458 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.71 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 2.2 t30 -62.7 -16.87 59.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.335 0.588 . . . . 0.0 110.878 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 89.34 13.32 61.85 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.71 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.9 m-85 -124.91 160.34 29.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.638 0.733 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 68.5 m -77.88 122.15 25.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.569 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.742 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.923 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.699 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.71 0.29 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.28 132.32 45.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -78.96 132.09 36.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.687 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.0 t -160.92 129.24 2.92 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.15 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 64.7 Cg_endo -73.56 161.12 42.92 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 111.26 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.7 mmt-85 -80.0 61.19 3.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.395 0.617 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -94.45 155.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.731 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' CD2' ' A' ' 28' ' ' TYR . 26.7 mt -117.44 105.91 12.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.75 126.37 12.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 48.0 mtpt -63.75 118.94 9.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.7 p -89.17 135.76 33.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.835 0.826 . . . . 0.0 113.174 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.26 -2.17 22.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.294 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 168.64 160.55 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.653 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.11 -41.02 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.84 0.352 . . . . 0.0 110.95 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -64.62 -16.02 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.335 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.19 -17.02 47.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.928 0.871 . . . . 0.0 109.238 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 91.5 m -89.73 140.43 27.98 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.26 146.18 56.38 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.927 2.418 . . . . 0.0 113.366 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.76 -129.09 47.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.288 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 94.5 mt-10 -102.17 23.26 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.575 0.226 . . . . 0.0 110.804 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.56 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 91.4 m -68.59 140.7 55.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.68 155.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -77.57 103.35 7.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.811 ' HB3' ' HZ1' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -84.1 170.3 13.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.962 -179.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.83 -34.48 29.75 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 116.333 1.293 . . . . 0.0 116.333 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.4 p-10 -78.47 8.59 4.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.102 0.951 . . . . 0.0 111.888 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.19 26.45 72.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.992 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m-85 -125.64 156.88 38.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 110.374 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.4 m -77.77 120.21 22.36 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.788 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.685 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.635 ' HG3' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -67.42 126.34 28.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.209 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.97 135.01 33.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.438 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.0 t -157.3 131.23 4.88 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.984 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.7 Cg_endo -76.17 163.26 33.04 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.719 2.279 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.494 HH22 HD23 ' A' ' 8' ' ' LEU . 37.8 tpt85 -74.26 66.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.341 0.591 . . . . 0.0 110.713 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -88.86 156.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.494 HD23 HH22 ' A' ' 6' ' ' ARG . 10.9 mt -121.72 64.56 0.9 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.38 124.63 52.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.526 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.93 122.59 17.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 12.9 p -96.94 138.98 33.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 15.1 ptm180 -110.28 -1.34 17.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.16 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' HG2' ' HG3' ' A' ' 12' ' ' ARG . 16.8 ptm180 172.63 157.47 0.1 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.009 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -58.2 -39.02 77.9 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 123.458 0.473 . . . . 0.0 111.085 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -62.73 -20.57 65.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.497 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.495 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 44.7 t0 -80.99 -15.29 56.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.932 0.872 . . . . 0.0 109.728 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 87.4 m -89.94 139.81 27.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.016 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.42 146.23 39.41 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.839 2.359 . . . . 0.0 113.476 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.01 -129.97 48.7 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.464 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 55.3 mt-10 -98.7 19.07 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.5 m -67.21 137.63 56.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.158 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 pt -115.83 156.14 16.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -77.03 100.96 5.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.692 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -80.23 153.85 28.28 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.338 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.25 3.96 Favored Glycine 0 N--CA 1.468 0.781 0 O-C-N 123.546 0.529 . . . . 0.0 114.108 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.615 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.9 t30 -61.39 -20.23 62.8 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.887 0.475 . . . . 0.0 111.043 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.79 9.06 57.76 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.85 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.615 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.2 m-85 -123.95 163.45 21.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.565 0.698 . . . . 0.0 110.401 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 93.6 m -75.72 127.55 33.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.692 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.951 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.035 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.973 0.416 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.611 ' HD3' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -117.01 135.76 53.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -95.53 138.39 33.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.462 . . . . 0.0 111.56 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 51.9 t -151.26 134.34 8.86 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 83.5 Cg_endo -81.94 -151.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.901 2.401 . . . . 0.0 112.431 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 30.6 tpt180 -94.61 113.4 25.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 7' ' ' ILE . 14.8 tt -150.64 156.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.479 HD22 ' CD2' ' A' ' 28' ' ' TYR . 14.8 mt -133.1 68.52 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.463 0.649 . . . . 0.0 110.745 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.38 125.24 52.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -64.11 118.32 8.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.41 136.21 33.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.028 0.918 . . . . 0.0 113.383 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -106.08 -6.12 18.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.336 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 167.03 158.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.74 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.55 -43.78 72.3 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.44 0.463 . . . . 0.0 111.166 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 m -63.0 -20.67 65.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.999 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -83.78 -10.29 58.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.848 0.832 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.4 m -92.38 143.55 27.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 143.55 43.95 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.617 2.211 . . . . 0.0 113.278 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.32 -128.55 47.5 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.605 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 36.7 mt-10 -96.9 10.0 40.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.326 0.108 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.3 m -62.65 138.64 58.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 110.364 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.611 HG23 ' HD3' ' A' ' 2' ' ' ARG . 31.7 pt -115.43 163.84 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.817 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.29 98.39 8.12 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.689 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -79.48 153.95 29.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.384 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.67 -28.12 4.98 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 123.537 0.523 . . . . 0.0 114.106 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 2.0 t30 -61.13 -20.24 62.44 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.929 0.492 . . . . 0.0 111.207 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.7 9.37 57.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.827 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.608 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.4 m-85 -123.1 165.61 16.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.511 0.672 . . . . 0.0 110.331 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -77.6 128.63 34.45 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.065 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.689 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.11 0 CA-C-O 118.171 -1.349 . . . . 0.0 111.143 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.804 0.335 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.724 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 38.8 mmt180 -69.78 139.15 53.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.685 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -80.45 134.31 35.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 t -156.05 131.11 5.25 Favored Pre-proline 0 C--N 1.319 -0.717 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.619 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.5 Cg_endo -71.57 152.67 59.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.681 2.254 . . . . 0.0 111.39 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -73.92 65.47 1.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.413 0.625 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 8' ' ' LEU . 10.2 tp -105.76 165.79 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.864 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 28' ' ' TYR . 54.2 mt -128.35 105.08 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.223 0.535 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.3 tmtm? -147.09 129.57 15.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.911 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -68.01 130.74 43.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.599 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 7.5 p -110.25 149.03 30.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.583 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -113.04 2.28 15.66 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 170.5 162.52 0.07 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.776 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.38 -35.31 71.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.884 0.373 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -62.21 -25.46 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.078 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.535 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 51.8 t0 -76.72 -18.97 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.799 0.809 . . . . 0.0 109.492 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 92.6 m -88.89 138.07 29.54 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.843 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 146.65 41.3 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.855 2.37 . . . . 0.0 113.259 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.28 -130.4 48.81 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.334 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 51.9 mt-10 -99.52 18.13 18.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.796 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.16 139.04 58.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -113.2 154.63 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.276 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -78.74 98.95 6.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -75.95 155.52 35.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.389 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.17 -30.95 5.82 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 123.546 0.529 . . . . 0.0 114.102 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.659 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.6 t30 -61.54 -17.77 56.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.437 0.637 . . . . 0.0 111.122 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.64 13.11 58.65 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.852 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.659 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.8 m-85 -120.11 162.58 19.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.162 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.9 m -80.13 125.31 29.66 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.31 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.5 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.44 -1.083 0 CA-C-O 118.283 -1.287 . . . . 0.0 111.017 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.306 0.574 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.61 147.74 50.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.1 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -81.63 139.08 35.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.109 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.1 t -158.45 131.18 4.44 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 121.002 0.43 . . . . 0.0 111.382 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.76 153.8 59.07 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.947 2.431 . . . . 0.0 110.772 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.475 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -70.32 114.17 8.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.098 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 tt -150.17 156.92 6.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.386 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.48 HD23 ' CD2' ' A' ' 28' ' ' TYR . 34.8 mt -122.4 83.73 2.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.443 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -129.51 126.13 37.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.0 mtpm? -64.41 124.26 21.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.6 p -92.99 142.93 26.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.016 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -106.0 -8.61 17.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 175.57 165.69 0.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.406 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -61.29 -42.41 98.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -68.87 -5.67 22.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.8 -13.41 31.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.733 . . . . 0.0 109.22 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 90.7 m -89.9 143.6 30.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.995 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.98 145.6 80.18 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.749 2.299 . . . . 0.0 112.824 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.57 -126.67 42.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.991 -0.624 . . . . 0.0 111.948 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 7.1 pt-20 -109.13 22.45 15.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.697 0.284 . . . . 0.0 110.541 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.4 m -65.13 150.57 47.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.123 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 22' ' ' ILE . 37.9 pt -116.88 158.26 17.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 111.51 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 t -82.36 97.31 8.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.581 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -71.19 153.22 42.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.345 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.97 -32.37 6.15 Favored Glycine 0 N--CA 1.468 0.831 0 O-C-N 123.547 0.529 . . . . 0.0 114.129 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.617 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -61.39 -19.45 61.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.402 0.62 . . . . 0.0 110.992 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 18.87 36.06 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.022 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.7 m-85 -123.8 161.42 25.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.261 0.553 . . . . 0.0 110.007 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 64.5 m -80.65 125.23 29.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.066 0 CA-C-O 118.36 -1.244 . . . . 0.0 111.156 179.432 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.0 0.429 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.493 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 1.1 mpp_? -62.67 138.56 58.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -85.12 144.21 28.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.826 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 45.7 t -159.21 135.67 6.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.373 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.75 -145.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.762 2.308 . . . . 0.0 111.673 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -110.99 118.35 35.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.52 154.91 8.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.3 mt -117.47 64.45 0.73 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.148 0.499 . . . . 0.0 111.288 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -110.24 121.54 45.51 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 111.34 4.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.5 p -87.34 150.7 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -122.66 1.9 9.48 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 166.38 158.1 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.73 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.67 -39.02 73.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.492 0.495 . . . . 0.0 111.202 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -61.77 -23.08 65.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.345 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.48 -9.46 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.833 0.825 . . . . 0.0 109.906 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.9 m -93.41 142.67 25.53 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.03 144.05 80.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.803 2.335 . . . . 0.0 112.682 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.86 -125.25 38.55 Favored Glycine 0 CA--C 1.509 -0.327 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 10.9 pt-20 -112.44 26.5 10.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.884 0.374 . . . . 0.0 110.054 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.6 m -63.57 148.11 49.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.775 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 30' ' ' GLY . 23.0 pt -112.18 155.45 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.308 0.575 . . . . 0.0 111.71 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.34 97.51 7.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -80.0 158.01 26.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.923 -178.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.93 3.88 Favored Glycine 0 N--CA 1.468 0.812 0 O-C-N 123.546 0.529 . . . . 0.0 114.003 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.642 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 6.2 t30 -62.41 -14.76 44.02 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.441 0.638 . . . . 0.0 110.964 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.14 74.96 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.642 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.2 m-85 -122.83 166.76 14.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.387 0.613 . . . . 0.0 110.129 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 92.6 m -78.48 126.94 31.46 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.0 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 22' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-O 118.256 -1.302 . . . . 0.0 110.98 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.548 ' NE ' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.1 126.16 27.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.296 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.26 137.63 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.218 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 1.6 t -167.76 126.22 0.99 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.767 0.318 . . . . 0.0 111.785 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.577 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 49.5 Cg_endo -68.44 137.55 39.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.711 2.274 . . . . 0.0 110.161 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.692 ' NH1' ' HA2' ' A' ' 30' ' ' GLY . 1.2 tpp180 -76.25 119.57 20.34 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.429 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -149.77 151.79 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.985 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 28' ' ' TYR . 12.5 mt -100.67 72.88 1.57 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 3.1 tmtm? -118.58 127.48 53.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.737 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.82 123.29 19.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.537 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . 28.4 p -102.28 146.04 28.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.958 0.885 . . . . 0.0 113.303 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' A' ' 12' ' ' ARG . 4.5 mmp_? -114.46 -9.72 12.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.068 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 7.0 ptp85 178.64 161.07 0.65 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.1 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 -39.54 81.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.812 0.339 . . . . 0.0 110.804 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 11' ' ' CYS . 3.5 t70 -84.89 -15.81 43.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.812 0.815 . . . . 0.0 109.285 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 40.1 m -87.8 144.39 34.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.378 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.93 143.27 59.96 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.484 2.123 . . . . 0.0 112.834 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.21 -126.57 42.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.859 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.548 ' HB3' ' NE ' ' A' ' 2' ' ' ARG . 3.4 mt-10 -107.17 27.62 8.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.782 0.325 . . . . 0.0 111.043 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.577 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 56.2 m -70.13 148.13 49.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 22' ' ' ILE . 39.1 pt -112.61 152.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.0 110.902 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -81.84 102.0 10.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.168 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 6.5 ptmt -87.78 158.89 18.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.651 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.34 -26.71 3.59 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.8 0.688 . . . . 0.0 114.058 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.638 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 7.5 t30 -61.17 -17.04 50.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.446 0.641 . . . . 0.0 110.807 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.71 69.2 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.638 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.1 m-85 -126.09 165.83 18.12 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.664 0.745 . . . . 0.0 110.385 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 98.9 m -78.43 122.85 26.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.841 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.692 ' HA2' ' NH1' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.44 -1.097 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.962 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.434 ' CZ ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -68.81 140.05 55.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.026 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -85.94 134.15 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.6 t -145.01 124.52 6.99 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.968 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.688 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.6 Cg_endo -70.39 154.96 64.81 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.126 2.55 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -66.17 96.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.491 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 7' ' ' ILE . 14.5 tt -150.49 153.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.954 0.407 . . . . 0.0 110.49 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -146.39 130.98 17.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -61.22 128.04 34.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.989 0.423 . . . . 0.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.5 p -92.65 142.58 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.504 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -107.13 -14.75 14.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.469 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 174.97 161.35 0.21 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.479 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -56.06 -45.64 79.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.004 0.431 . . . . 0.0 111.074 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.6 t -65.65 -17.07 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.449 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -13.69 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.656 0.741 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.0 m -88.66 143.59 32.16 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 144.33 58.21 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.797 2.331 . . . . 0.0 113.32 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.56 -128.96 48.05 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 91.0 mt-10 -101.23 17.5 22.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.501 0.191 . . . . 0.0 110.563 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.688 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 87.3 m -67.25 140.86 57.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.434 HD13 ' CZ ' ' A' ' 2' ' ' ARG . 38.6 pt -115.61 159.18 15.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.59 97.02 5.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.754 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 5.7 ptmt -77.31 156.34 31.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.957 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.24 -30.83 5.91 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 123.53 0.519 . . . . 0.0 114.142 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.653 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.9 t30 -62.01 -16.59 52.74 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.604 0.716 . . . . 0.0 110.963 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.88 22.42 46.02 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-85 -128.67 164.1 23.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.5 m -79.99 125.22 29.49 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.806 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.662 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.076 0.465 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 21.1 mmm180 -107.25 179.16 4.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.509 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -77.65 134.37 38.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.014 0.435 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.4 t -155.28 128.15 4.2 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.626 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.3 Cg_endo -71.31 146.11 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.685 2.257 . . . . 0.0 111.196 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -66.44 101.42 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.943 0.401 . . . . 0.0 110.772 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.42 152.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.45 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.12 108.1 16.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.565 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.8 tmtm? -146.06 129.69 17.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.483 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.06 131.77 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -117.26 139.81 50.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.356 0.598 . . . . 0.0 111.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -101.94 0.2 34.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 177.66 163.02 0.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.909 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -60.27 -38.04 82.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.736 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -63.72 -18.78 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.01 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.565 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 50.8 t0 -78.87 -18.52 53.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.0 m -88.44 140.96 30.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.345 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.29 145.77 30.87 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.751 2.301 . . . . 0.0 113.444 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.23 -130.5 49.03 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.52 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 94.3 mt-10 -97.62 16.13 21.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.994 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.3 139.72 58.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.93 154.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.887 0.375 . . . . 0.0 110.269 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -80.55 99.68 8.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -76.51 154.54 34.53 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.314 -179.378 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.58 -27.65 4.52 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 123.537 0.523 . . . . 0.0 114.14 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.646 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.8 t30 -62.33 -18.28 61.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.81 9.0 60.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.761 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-85 -121.27 163.14 19.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.562 0.696 . . . . 0.0 110.732 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 68.4 m -78.02 126.06 30.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.387 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.55 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.92 0 CA-C-O 118.272 -1.294 . . . . 0.0 111.161 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 132.68 54.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.582 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.85 137.49 53.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.748 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.407 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 49.4 t -154.18 137.53 10.43 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 48.9 Cg_endo -68.39 163.42 36.57 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.682 2.254 . . . . 0.0 111.229 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -75.54 63.61 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.189 0.519 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.85 155.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 73.12 1.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.247 0.546 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HZ2' ' CG ' ' A' ' 16' ' ' ASP . 12.4 tmtt? -122.35 126.1 47.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.361 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.5 mtpm? -62.66 126.62 27.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.046 0.451 . . . . 0.0 110.35 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 8.4 p -95.47 141.53 28.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.169 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.65 -13.86 22.52 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.2 ptp180 170.54 164.87 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.452 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.79 -41.11 77.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.741 0.305 . . . . 0.0 111.159 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -64.36 -21.79 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.187 0.518 . . . . 0.0 111.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 16.0 t70 -82.14 -13.34 57.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.76 0.79 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.3 m -89.54 140.8 28.32 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.0 143.1 64.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.874 2.383 . . . . 0.0 113.25 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.25 -131.54 42.0 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 113.725 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -93.32 24.86 3.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 94.9 m -77.99 143.35 37.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 pt -114.16 160.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.837 0.351 . . . . 0.0 110.482 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 t -83.06 97.8 8.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.686 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 2.8 ptmm? -74.68 166.6 23.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.213 0.53 . . . . 0.0 112.266 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.45 -37.67 26.15 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.178 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.686 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -79.52 16.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.761 0.78 . . . . 0.0 112.022 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 63.33 32.99 86.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.896 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.6 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -126.48 162.63 25.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 58.3 m -82.08 121.85 27.09 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.107 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.035 -1.425 . . . . 0.0 111.149 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.894 0.378 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -67.98 146.99 53.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.29 139.19 8.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 17.1 t -144.93 136.16 12.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.859 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 93.9 Cg_endo -80.05 -149.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.789 2.326 . . . . 0.0 111.958 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.429 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 18.3 tpp85 -90.45 102.63 15.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.25 154.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.577 HD22 ' CD2' ' A' ' 28' ' ' TYR . 37.2 mt -135.67 104.5 5.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.66 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.35 125.25 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.6 mtpt -66.43 119.11 11.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.619 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -97.22 135.84 38.58 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 13.6 ptm180 -102.4 6.46 40.23 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 165.76 157.79 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.49 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.73 -33.28 72.66 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.242 0.339 . . . . 0.0 110.929 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 42.2 t0 -82.17 -9.53 59.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.779 0.799 . . . . 0.0 110.069 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 93.5 m -89.97 137.97 27.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.317 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.56 144.99 46.11 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.852 2.368 . . . . 0.0 113.261 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.86 -131.36 47.54 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.419 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.5 22.37 6.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 72.7 m -76.67 142.82 40.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.443 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -113.82 159.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.76 97.34 8.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.585 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 3.0 ptpt -75.48 153.01 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.757 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.2 -28.88 4.6 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 123.665 0.603 . . . . 0.0 114.198 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.657 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -61.41 -21.15 63.83 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.164 0.507 . . . . 0.0 111.151 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 98.28 9.96 52.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.71 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.4 m-85 -122.0 157.76 30.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.703 0.764 . . . . 0.0 110.871 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 72.7 m -77.74 126.64 31.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.461 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 45.4 Cg_endo -71.73 130.07 16.44 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.113 1.876 . . . . 0.0 109.562 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -72.29 118.91 15.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.136 0.494 . . . . 0.0 111.381 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -148.52 151.97 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.276 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.453 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 16.5 mt -93.39 75.58 4.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.976 0.417 . . . . 0.0 111.852 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.519 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 4.6 tmtm? -122.36 122.94 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 9.3 mtpp -65.83 126.2 27.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.962 0.41 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 7.6 p -100.72 139.9 35.76 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.092 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -104.09 1.37 30.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 165.96 164.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.764 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -58.99 -39.15 80.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.073 0.463 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 t -64.17 -19.27 65.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.393 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 47.8 t0 -79.84 -18.01 51.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.78 0.8 . . . . 0.0 109.431 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 76.4 m -88.8 143.17 31.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.24 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 145.82 50.33 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.869 2.379 . . . . 0.0 113.198 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.37 -130.19 50.67 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.2 26.11 7.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.5 m -69.34 144.17 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.5 pt -114.4 156.06 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -79.02 105.66 10.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.9 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 57.2 mtpt -67.28 156.32 36.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.26 47.16 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.776 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 28' ' ' TYR . 11.4 p-10 -74.89 -6.04 47.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 87.18 29.62 22.07 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.268 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 4.3 m-85 -128.32 156.45 43.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.519 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 75.9 m -74.04 127.08 31.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.9 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.931 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.973 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.236 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 61.2 Cg_endo -73.12 -146.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.86 2.373 . . . . 0.0 112.07 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.48 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 86.7 mmt-85 -127.84 100.35 5.9 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.96 0.41 . . . . 0.0 110.037 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -151.24 155.58 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.513 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 80.3 mt -118.7 107.98 14.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.096 0.474 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -143.57 126.62 16.41 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.3 mttt -65.67 126.9 29.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.049 0.452 . . . . 0.0 110.508 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.0 p -112.63 145.3 40.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.481 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -99.87 -1.39 37.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.393 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 6.0 ptp85 178.08 164.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.567 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.1 -40.54 94.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.995 0.426 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -65.91 -12.89 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 46.6 t0 -86.23 4.02 40.55 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.007 0.908 . . . . 0.0 109.608 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 97.4 m -111.9 138.76 21.75 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.828 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 145.64 77.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.796 2.331 . . . . 0.0 113.455 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.83 -130.96 50.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.115 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -100.78 19.23 17.53 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.551 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 99.1 m -65.84 141.36 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -114.12 155.62 15.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.756 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -78.72 100.0 6.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.75 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 1.1 ptpm? -71.01 168.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.742 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -48.62 -40.45 24.89 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -81.12 18.64 1.02 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.346 0.573 . . . . 0.0 112.221 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 64.16 35.49 92.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.756 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.75 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.4 m-85 -125.05 157.73 35.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.363 0.601 . . . . 0.0 110.33 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 62.8 m -81.52 116.84 21.49 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.67 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.922 0 CA-C-O 118.24 -1.311 . . . . 0.0 111.021 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 18.6 t . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.3 Cg_endo -71.37 147.42 52.71 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.724 2.283 . . . . 0.0 110.836 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -59.41 114.12 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.103 0.478 . . . . 0.0 110.987 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -146.02 159.56 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.203 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 17.0 mt -128.27 81.55 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 111.021 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.4 125.78 35.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.168 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 7.3 mttm -67.14 117.42 9.15 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 p -91.06 143.88 26.24 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -106.35 -9.03 16.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.425 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 175.02 163.99 0.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.857 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -60.13 -36.03 76.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.719 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.72 -23.02 67.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.232 0.539 . . . . 0.0 110.675 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -79.41 -19.1 50.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.034 0.921 . . . . 0.0 109.307 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 88.3 m -89.89 140.9 27.82 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.596 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.52 143.03 46.03 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.541 2.161 . . . . 0.0 113.442 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 -131.4 46.55 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.505 -0.771 . . . . 0.0 113.629 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.71 20.01 4.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 84.1 m -73.21 140.01 46.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.543 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.4 pt -112.47 156.53 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.235 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.1 100.21 8.92 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -71.75 153.29 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.199 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.49 -33.66 17.92 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.598 0.561 . . . . 0.0 113.512 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -61.34 -21.12 63.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.851 0.834 . . . . 0.0 110.184 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 93.95 25.74 16.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.828 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 5.7 m-85 -129.26 155.71 45.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 89.1 m -72.8 125.28 27.17 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.705 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.17 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.4 Cg_endo -65.98 142.19 67.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.422 2.081 . . . . 0.0 110.132 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -75.05 63.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.464 0.65 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -98.97 153.85 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.71 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -109.83 107.34 17.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.103 0.477 . . . . 0.0 111.412 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -147.46 125.87 12.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.251 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 14.7 mtpp -67.14 131.46 45.84 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.813 0.339 . . . . 0.0 110.375 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.5 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.7 p -109.93 139.59 44.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.125 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.427 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 16.5 ptm180 -97.79 -0.83 44.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.431 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 12.2 ptm180 177.98 163.95 0.66 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.51 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -46.78 84.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.0 110.571 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 t -64.81 -11.8 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.56 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 37.8 t0 -82.86 -1.41 51.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.819 0.819 . . . . 0.0 110.14 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.6 m -104.51 141.72 23.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.291 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.76 146.43 48.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.974 2.45 . . . . 0.0 113.596 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -132.39 51.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -96.81 19.7 12.17 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 85.1 m -69.06 139.23 54.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 pt -118.83 154.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.242 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -76.6 104.46 7.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.7 0.762 . . . . 0.0 110.258 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -78.1 156.3 30.06 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.5 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.93 -32.23 8.65 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.49 0.494 . . . . 0.0 113.931 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.538 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -62.59 -16.65 57.46 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.657 0.741 . . . . 0.0 110.941 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.62 22.27 44.04 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.538 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 4.5 m-85 -126.57 158.43 36.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.214 0.531 . . . . 0.0 109.779 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.1 m -77.76 120.8 23.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.56 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.443 -1.198 . . . . 0.0 111.781 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 121.13 0.49 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.0 Cg_endo -77.04 146.89 26.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.815 2.343 . . . . 0.0 110.971 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -61.11 113.91 2.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.83 159.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.652 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.12 82.03 2.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.306 0.574 . . . . 0.0 110.074 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -130.73 128.28 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.664 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.4 mtpt -63.94 124.43 21.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.364 0.415 . . . . 0.0 110.057 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.664 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.3 p -96.81 144.88 26.36 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.981 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -106.49 -13.74 15.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.664 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 175.79 165.14 0.36 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -59.02 -38.47 79.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.874 0.369 . . . . 0.0 110.543 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -20.6 66.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.031 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.65 -15.61 48.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 109.673 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 84.6 m -90.48 140.39 26.82 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.557 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 144.41 61.26 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.518 2.145 . . . . 0.0 112.967 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.99 -130.03 50.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.18 16.38 24.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.955 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.621 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.8 m -60.45 140.9 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.102 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 pt -111.28 152.63 13.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.165 0.507 . . . . 0.0 111.166 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.1 96.41 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.811 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -79.31 169.11 18.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 112.449 -177.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.07 -35.59 26.31 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 116.3 1.28 . . . . 0.0 116.3 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.443 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.5 p-10 -77.7 8.8 4.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.995 0.897 . . . . 0.0 111.81 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.33 25.82 73.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.098 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -124.29 158.63 32.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 110.254 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.5 m -80.75 122.64 27.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.876 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.811 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.955 0 CA-C-O 118.257 -1.302 . . . . 0.0 111.453 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.47 -156.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.898 2.398 . . . . 0.0 111.863 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -94.86 117.53 30.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.13 157.83 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.905 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 18.3 mt -132.43 70.96 1.46 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.384 0.611 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HE2' ' OD2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -118.39 124.92 48.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.67 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -66.78 119.08 11.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.539 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -94.18 142.92 26.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.792 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -114.01 5.32 16.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.0 ptp180 166.96 158.32 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.744 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -58.64 -38.34 77.88 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.217 0.323 . . . . 0.0 111.131 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -63.37 -20.14 65.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.188 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 15.5 t70 -82.53 -12.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.811 0.815 . . . . 0.0 110.19 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 68.1 m -89.98 140.25 27.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.006 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.92 146.31 47.24 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.788 2.325 . . . . 0.0 113.313 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.5 -128.59 47.32 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.305 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -102.99 18.17 22.32 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 72.3 m -65.94 142.71 57.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.8 pt -113.77 155.97 14.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.72 99.52 5.12 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.616 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 14.3 mtpp -74.21 151.62 39.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.362 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.03 -25.31 9.88 Favored Glycine 0 C--N 1.339 0.706 0 O-C-N 123.468 0.48 . . . . 0.0 113.25 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.512 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 1.2 t-20 -61.87 -23.45 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.066 0.546 . . . . 0.0 110.752 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.43 53.46 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.512 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 3.3 m-85 -120.36 159.42 25.09 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.404 0.621 . . . . 0.0 110.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 94.5 m -73.95 131.48 41.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.485 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.616 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.882 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.546 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.4 t . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 2.8 Cg_exo -72.3 137.75 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.049 2.499 . . . . 0.0 110.376 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.4 mmt-85 -69.39 118.86 12.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.14 153.89 12.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.423 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 12.4 mt -97.45 66.96 2.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.954 0.407 . . . . 0.0 111.673 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.548 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.93 122.77 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.429 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -67.35 135.26 52.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -118.75 141.4 48.66 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -100.58 -11.26 20.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.906 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.9 ptp180 176.77 165.21 0.49 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.225 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -59.12 -36.71 75.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.715 0.293 . . . . 0.0 110.871 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -63.36 -24.46 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 110.548 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 33.5 t0 -78.59 -17.96 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.025 0.917 . . . . 0.0 109.972 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 74.7 m -88.4 135.94 32.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.62 143.69 63.37 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.652 2.235 . . . . 0.0 113.328 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.05 -131.75 50.33 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.112 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -93.96 21.13 6.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 90.7 m -72.79 141.01 48.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.338 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.05 152.81 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.998 0.428 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.2 t -80.51 95.3 6.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -75.15 156.66 35.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.882 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.55 -28.57 5.04 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.529 0.518 . . . . 0.0 114.216 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.525 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 1.3 t-20 -63.07 -16.35 59.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.454 0.645 . . . . 0.0 110.956 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' C ' ' HD1' ' A' ' 28' ' ' TYR . . . 88.8 17.75 55.87 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.625 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -127.26 158.61 36.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.671 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 91.8 m -78.8 120.39 23.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.015 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.502 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-O 118.508 -1.162 . . . . 0.0 111.952 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.676 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 58.7 Cg_endo -71.61 144.63 45.03 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.909 2.406 . . . . 0.0 110.826 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -66.81 102.39 0.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.845 0.355 . . . . 0.0 110.619 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -150.41 154.66 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.824 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.82 111.4 21.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.11 126.12 14.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.2 112.47 5.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.575 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.6 p -87.05 151.47 23.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -127.53 6.38 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 164.78 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.524 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -58.94 -35.41 73.06 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.21 0.319 . . . . 0.0 111.252 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -64.37 -22.65 67.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 111.193 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.76 -12.34 57.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.852 0.834 . . . . 0.0 109.924 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 60.9 m -89.99 137.68 28.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.325 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.87 145.91 76.19 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.846 2.364 . . . . 0.0 112.853 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.29 -126.27 41.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.827 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -108.97 22.23 16.19 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.782 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 88.2 m -64.76 147.2 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.733 0.301 . . . . 0.0 110.433 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 pt -112.01 153.86 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 0.0 110.771 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.1 t -79.35 95.35 5.69 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 5.8 ptmt -79.89 157.49 26.93 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.501 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.54 4.37 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.713 0.633 . . . . 0.0 114.055 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 3.5 t-20 -62.58 -14.18 39.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.564 0.697 . . . . 0.0 110.891 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.14 75.51 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.3 m-85 -121.05 167.88 12.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.565 0.698 . . . . 0.0 110.329 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 96.7 m -81.98 127.71 33.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.879 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 CA-C-O 118.22 -1.322 . . . . 0.0 111.432 179.818 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.236 0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.2 Cg_endo -65.38 153.29 78.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.913 2.409 . . . . 0.0 110.799 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.612 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -77.49 60.85 2.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -96.86 157.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 mt -123.13 105.06 9.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.21 0.528 . . . . 0.0 110.585 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -147.22 130.27 16.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.2 mttt -60.95 127.96 34.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 20.3 p -101.9 141.27 35.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -98.48 -17.67 18.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.503 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.9 ptp180 173.15 166.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.822 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -57.31 -39.24 75.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.88 -24.48 67.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.315 0.578 . . . . 0.0 110.683 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 14.8 t70 -81.73 -15.72 53.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.3 m -89.67 141.85 28.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.597 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.12 144.8 53.21 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.584 2.189 . . . . 0.0 113.204 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.73 -131.55 52.11 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.312 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -98.84 21.92 10.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.652 0.263 . . . . 0.0 111.074 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.2 m -67.68 141.36 56.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.29 153.17 14.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.063 0.459 . . . . 0.0 110.602 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.7 t -79.68 96.1 6.13 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.75 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -81.06 156.76 25.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.077 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.81 -27.25 3.16 Favored Glycine 0 N--CA 1.468 0.799 0 O-C-N 123.713 0.633 . . . . 0.0 114.458 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.565 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 1.8 t-20 -62.7 -16.87 59.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.335 0.588 . . . . 0.0 110.878 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 89.34 13.32 61.85 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.565 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 3.9 m-85 -124.91 160.34 29.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.638 0.733 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 68.5 m -77.88 122.15 25.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.569 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.75 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.923 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.699 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 64.7 Cg_endo -73.56 161.12 42.92 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 111.26 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.7 mmt-85 -80.0 61.19 3.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.395 0.617 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -94.45 155.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.731 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 mt -117.44 105.91 12.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.75 126.37 12.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 48.0 mtpt -63.75 118.94 9.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.7 p -89.17 135.76 33.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.835 0.826 . . . . 0.0 113.174 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.26 -2.17 22.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.294 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 168.64 160.55 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.653 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.11 -41.02 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.84 0.352 . . . . 0.0 110.95 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -64.62 -16.02 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.335 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.19 -17.02 47.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.928 0.871 . . . . 0.0 109.238 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 91.5 m -89.73 140.43 27.98 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.26 146.18 56.38 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.927 2.418 . . . . 0.0 113.366 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.76 -129.09 47.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.288 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -102.17 23.26 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.575 0.226 . . . . 0.0 110.804 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 91.4 m -68.59 140.7 55.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.68 155.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -77.57 103.35 7.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.797 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -84.1 170.3 13.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.962 -179.12 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.83 -34.48 29.75 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 116.333 1.293 . . . . 0.0 116.333 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.4 p-10 -78.47 8.59 4.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.102 0.951 . . . . 0.0 111.888 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.19 26.45 72.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.992 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.552 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m-85 -125.64 156.88 38.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 110.374 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.4 m -77.77 120.21 22.36 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.797 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.685 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.433 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.0 t . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.7 Cg_endo -76.17 163.26 33.04 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.719 2.279 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 6' ' ' ARG . 37.8 tpt85 -74.26 66.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.341 0.591 . . . . 0.0 110.713 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -88.86 156.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 10.9 mt -121.72 64.56 0.9 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.38 124.63 52.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.526 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.93 122.59 17.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 12.9 p -96.94 138.98 33.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.491 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 15.1 ptm180 -110.28 -1.34 17.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.16 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HG2' ' HG3' ' A' ' 12' ' ' ARG . 16.8 ptm180 172.63 157.47 0.1 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.009 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -58.2 -39.02 77.9 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 123.458 0.473 . . . . 0.0 111.085 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -62.73 -20.57 65.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.497 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.491 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 44.7 t0 -80.99 -15.29 56.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.932 0.872 . . . . 0.0 109.728 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 87.4 m -89.94 139.81 27.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.016 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.42 146.23 39.41 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.839 2.359 . . . . 0.0 113.476 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.01 -129.97 48.7 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.464 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -98.7 19.07 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.74 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.5 m -67.21 137.63 56.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.158 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 pt -115.83 156.14 16.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -77.03 100.96 5.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.701 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -80.23 153.85 28.28 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.338 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.25 3.96 Favored Glycine 0 N--CA 1.468 0.781 0 O-C-N 123.546 0.529 . . . . 0.0 114.108 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.513 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 1.9 t-20 -61.39 -20.23 62.8 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.887 0.475 . . . . 0.0 111.043 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.79 9.06 57.76 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.85 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.2 m-85 -123.95 163.45 21.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.565 0.698 . . . . 0.0 110.401 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 93.6 m -75.72 127.55 33.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.701 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.951 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.035 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 51.9 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.94 -151.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.901 2.401 . . . . 0.0 112.431 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -94.61 113.4 25.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.64 156.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.8 mt -133.1 68.52 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.463 0.649 . . . . 0.0 110.745 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.38 125.24 52.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -64.11 118.32 8.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.41 136.21 33.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.028 0.918 . . . . 0.0 113.383 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -106.08 -6.12 18.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.336 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 167.03 158.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.74 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.55 -43.78 72.3 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.44 0.463 . . . . 0.0 111.166 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 m -63.0 -20.67 65.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.999 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -83.78 -10.29 58.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.848 0.832 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.4 m -92.38 143.55 27.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 143.55 43.95 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.617 2.211 . . . . 0.0 113.278 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.32 -128.55 47.5 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.605 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -96.9 10.0 40.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.326 0.108 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.3 m -62.65 138.64 58.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 110.364 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.43 163.84 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.817 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.29 98.39 8.12 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.696 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -79.48 153.95 29.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.384 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.67 -28.12 4.98 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 123.537 0.523 . . . . 0.0 114.106 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.462 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 2.0 t-20 -61.13 -20.24 62.44 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.929 0.492 . . . . 0.0 111.207 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.7 9.37 57.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.827 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.627 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.4 m-85 -123.1 165.61 16.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.511 0.672 . . . . 0.0 110.331 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -77.6 128.63 34.45 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.065 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.696 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.11 0 CA-C-O 118.171 -1.349 . . . . 0.0 111.143 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.59 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.5 Cg_endo -71.57 152.67 59.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.681 2.254 . . . . 0.0 111.39 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -73.92 65.47 1.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.413 0.625 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 8' ' ' LEU . 10.2 tp -105.76 165.79 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.864 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 7' ' ' ILE . 54.2 mt -128.35 105.08 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.223 0.535 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.3 tmtm? -147.09 129.57 15.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.911 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -68.01 130.74 43.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 7.5 p -110.25 149.03 30.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.583 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -113.04 2.28 15.66 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 170.5 162.52 0.07 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.776 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.38 -35.31 71.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.884 0.373 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -62.21 -25.46 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.078 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 51.8 t0 -76.72 -18.97 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.799 0.809 . . . . 0.0 109.492 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 92.6 m -88.89 138.07 29.54 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.843 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 146.65 41.3 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.855 2.37 . . . . 0.0 113.259 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.28 -130.4 48.81 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.334 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.52 18.13 18.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.796 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.16 139.04 58.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -113.2 154.63 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.276 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -78.74 98.95 6.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -75.95 155.52 35.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.389 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.17 -30.95 5.82 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 123.546 0.529 . . . . 0.0 114.102 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 1.3 t-20 -61.54 -17.77 56.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.437 0.637 . . . . 0.0 111.122 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.64 13.11 58.65 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.852 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.64 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.8 m-85 -120.11 162.58 19.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.162 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.9 m -80.13 125.31 29.66 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.31 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.506 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.44 -1.083 0 CA-C-O 118.283 -1.287 . . . . 0.0 111.017 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 59.0 Cg_endo -71.76 153.8 59.07 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.947 2.431 . . . . 0.0 110.772 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -70.32 114.17 8.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.098 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 tt -150.17 156.92 6.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.386 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.4 83.73 2.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.443 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -129.51 126.13 37.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.0 mtpm? -64.41 124.26 21.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.6 p -92.99 142.93 26.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.016 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -106.0 -8.61 17.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' ' 16' ' ' ASP . 22.2 ptt180 175.57 165.69 0.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.406 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -61.29 -42.41 98.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -68.87 -5.67 22.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 37.6 t70 -91.8 -13.41 31.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.733 . . . . 0.0 109.22 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 90.7 m -89.9 143.6 30.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.995 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.98 145.6 80.18 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.749 2.299 . . . . 0.0 112.824 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.57 -126.67 42.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.991 -0.624 . . . . 0.0 111.948 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.13 22.45 15.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.697 0.284 . . . . 0.0 110.541 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.4 m -65.13 150.57 47.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.123 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.9 pt -116.88 158.26 17.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 111.51 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 t -82.36 97.31 8.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.581 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -71.19 153.22 42.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.345 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.97 -32.37 6.15 Favored Glycine 0 N--CA 1.468 0.831 0 O-C-N 123.547 0.529 . . . . 0.0 114.129 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -61.39 -19.45 61.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.402 0.62 . . . . 0.0 110.992 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 18.87 36.06 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.022 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.676 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.7 m-85 -123.8 161.42 25.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.261 0.553 . . . . 0.0 110.007 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 64.5 m -80.65 125.23 29.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.066 0 CA-C-O 118.36 -1.244 . . . . 0.0 111.156 179.432 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 45.7 t . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 88.0 Cg_endo -78.75 -145.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.762 2.308 . . . . 0.0 111.673 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 51.4 mmm-85 -110.99 118.35 35.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.52 154.91 8.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.3 mt -117.47 64.45 0.73 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.148 0.499 . . . . 0.0 111.288 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -110.24 121.54 45.51 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 111.34 4.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.526 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.5 p -87.34 150.7 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -122.66 1.9 9.48 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 166.38 158.1 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.73 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.67 -39.02 73.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.492 0.495 . . . . 0.0 111.202 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -61.77 -23.08 65.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.345 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.48 -9.46 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.833 0.825 . . . . 0.0 109.906 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.9 m -93.41 142.67 25.53 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.03 144.05 80.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.803 2.335 . . . . 0.0 112.682 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.86 -125.25 38.55 Favored Glycine 0 CA--C 1.509 -0.327 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.44 26.5 10.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.884 0.374 . . . . 0.0 110.054 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.6 m -63.57 148.11 49.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.775 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 30' ' ' GLY . 23.0 pt -112.18 155.45 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.308 0.575 . . . . 0.0 111.71 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.34 97.51 7.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -80.0 158.01 26.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.923 -178.344 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.93 3.88 Favored Glycine 0 N--CA 1.468 0.812 0 O-C-N 123.546 0.529 . . . . 0.0 114.003 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.561 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 3.9 t-20 -62.41 -14.76 44.02 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.441 0.638 . . . . 0.0 110.964 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.14 74.96 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.53 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.2 m-85 -122.83 166.76 14.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.387 0.613 . . . . 0.0 110.129 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 92.6 m -78.48 126.94 31.46 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.0 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.484 ' O ' HG12 ' A' ' 22' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-O 118.256 -1.302 . . . . 0.0 110.98 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 1.6 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.767 0.318 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 49.5 Cg_endo -68.44 137.55 39.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.711 2.274 . . . . 0.0 110.161 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.707 ' NH1' ' HA2' ' A' ' 30' ' ' GLY . 1.2 tpp180 -76.25 119.57 20.34 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.429 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -149.77 151.79 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.985 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.67 72.88 1.57 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 3.1 tmtm? -118.58 127.48 53.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.737 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.82 123.29 19.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . 28.4 p -102.28 146.04 28.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.958 0.885 . . . . 0.0 113.303 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.5 mmp_? -114.46 -9.72 12.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.068 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 7.0 ptp85 178.64 161.07 0.65 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.1 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 -39.54 81.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.812 0.339 . . . . 0.0 110.804 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' A' ' 11' ' ' CYS . 3.5 t70 -84.89 -15.81 43.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.812 0.815 . . . . 0.0 109.285 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 40.1 m -87.8 144.39 34.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.378 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.93 143.27 59.96 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.484 2.123 . . . . 0.0 112.834 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.21 -126.57 42.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.859 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -107.17 27.62 8.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.782 0.325 . . . . 0.0 111.043 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.2 m -70.13 148.13 49.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.61 152.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.0 110.902 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -81.84 102.0 10.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.168 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 6.5 ptmt -87.78 158.89 18.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.651 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.34 -26.71 3.59 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.8 0.688 . . . . 0.0 114.058 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.495 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 4.4 t-20 -61.17 -17.04 50.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.446 0.641 . . . . 0.0 110.807 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.71 69.2 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.538 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.1 m-85 -126.09 165.83 18.12 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.664 0.745 . . . . 0.0 110.385 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 98.9 m -78.43 122.85 26.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.841 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.707 ' HA2' ' NH1' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.44 -1.097 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.962 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.6 t . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.6 Cg_endo -70.39 154.96 64.81 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.126 2.55 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -66.17 96.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.491 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.49 153.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.954 0.407 . . . . 0.0 110.49 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -146.39 130.98 17.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -61.22 128.04 34.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.989 0.423 . . . . 0.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 21.5 p -92.65 142.58 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.504 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -107.13 -14.75 14.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.469 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 174.97 161.35 0.21 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.479 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -56.06 -45.64 79.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.004 0.431 . . . . 0.0 111.074 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.6 t -65.65 -17.07 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.449 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -13.69 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.656 0.741 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.0 m -88.66 143.59 32.16 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 144.33 58.21 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.797 2.331 . . . . 0.0 113.32 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.56 -128.96 48.05 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -101.23 17.5 22.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.501 0.191 . . . . 0.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.693 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 87.3 m -67.25 140.86 57.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -115.61 159.18 15.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.59 97.02 5.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.754 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 5.7 ptmt -77.31 156.34 31.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.957 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.24 -30.83 5.91 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 123.53 0.519 . . . . 0.0 114.142 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 1.5 t-20 -62.01 -16.59 52.74 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.604 0.716 . . . . 0.0 110.963 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.88 22.42 46.02 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.501 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 4.0 m-85 -128.67 164.1 23.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.5 m -79.99 125.22 29.49 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.806 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.543 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.662 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.3 Cg_endo -71.31 146.11 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.685 2.257 . . . . 0.0 111.196 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -66.44 101.42 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.943 0.401 . . . . 0.0 110.772 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.42 152.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.45 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.12 108.1 16.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.8 tmtm? -146.06 129.69 17.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.483 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.06 131.77 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -117.26 139.81 50.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.356 0.598 . . . . 0.0 111.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -101.94 0.2 34.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 177.66 163.02 0.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.909 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -60.27 -38.04 82.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.736 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -63.72 -18.78 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.01 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.587 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 50.8 t0 -78.87 -18.52 53.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.0 m -88.44 140.96 30.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.345 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.29 145.77 30.87 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.751 2.301 . . . . 0.0 113.444 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.23 -130.5 49.03 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.52 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -97.62 16.13 21.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.994 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.3 139.72 58.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.93 154.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.887 0.375 . . . . 0.0 110.269 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -80.55 99.68 8.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -76.51 154.54 34.53 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.314 -179.378 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.58 -27.65 4.52 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 123.537 0.523 . . . . 0.0 114.14 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.524 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 1.7 t-20 -62.33 -18.28 61.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.81 9.0 60.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.761 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.634 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.0 m-85 -121.27 163.14 19.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.562 0.696 . . . . 0.0 110.732 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 68.4 m -78.02 126.06 30.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.387 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.556 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.92 0 CA-C-O 118.272 -1.294 . . . . 0.0 111.161 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.405 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 49.4 t . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.613 0.244 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 48.9 Cg_endo -68.39 163.42 36.57 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.682 2.254 . . . . 0.0 111.229 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -75.54 63.61 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.189 0.519 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.85 155.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 73.12 1.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.247 0.546 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -122.35 126.1 47.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.361 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.5 mtpm? -62.66 126.62 27.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.046 0.451 . . . . 0.0 110.35 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.533 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 8.4 p -95.47 141.53 28.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.169 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.65 -13.86 22.52 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.2 ptp180 170.54 164.87 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.452 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.79 -41.11 77.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.741 0.305 . . . . 0.0 111.159 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -64.36 -21.79 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.187 0.518 . . . . 0.0 111.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 16.0 t70 -82.14 -13.34 57.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.76 0.79 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.3 m -89.54 140.8 28.32 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.0 143.1 64.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.874 2.383 . . . . 0.0 113.25 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.25 -131.54 42.0 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 113.725 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -93.32 24.86 3.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 94.9 m -77.99 143.35 37.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 30' ' ' GLY . 35.7 pt -114.16 160.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.837 0.351 . . . . 0.0 110.482 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 t -83.06 97.8 8.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.694 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 2.8 ptmm? -74.68 166.6 23.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.213 0.53 . . . . 0.0 112.266 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.45 -37.67 26.15 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.178 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.694 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -79.52 16.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.761 0.78 . . . . 0.0 112.022 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 63.33 32.99 86.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.896 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.595 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -126.48 162.63 25.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 58.3 m -82.08 121.85 27.09 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.107 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.035 -1.425 . . . . 0.0 111.149 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.05 -149.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.789 2.326 . . . . 0.0 111.958 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -90.45 102.63 15.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.25 154.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -135.67 104.5 5.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.66 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.35 125.25 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.6 mtpt -66.43 119.11 11.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -97.22 135.84 38.58 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 13.6 ptm180 -102.4 6.46 40.23 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 165.76 157.79 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.49 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.73 -33.28 72.66 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.242 0.339 . . . . 0.0 110.929 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 42.2 t0 -82.17 -9.53 59.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.779 0.799 . . . . 0.0 110.069 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 93.5 m -89.97 137.97 27.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.317 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.56 144.99 46.11 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.852 2.368 . . . . 0.0 113.261 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.86 -131.36 47.54 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.419 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.5 22.37 6.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 72.7 m -76.67 142.82 40.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.443 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -113.82 159.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.76 97.34 8.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.605 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 3.0 ptpt -75.48 153.01 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.757 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.2 -28.88 4.6 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 123.665 0.603 . . . . 0.0 114.198 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.605 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -61.41 -21.15 63.83 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.164 0.507 . . . . 0.0 111.151 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 98.28 9.96 52.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.71 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.4 m-85 -122.0 157.76 30.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.703 0.764 . . . . 0.0 110.871 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 72.7 m -77.74 126.64 31.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.461 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 23.6 mmt85 -80.71 154.21 27.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.36 135.75 55.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 t -159.89 131.11 3.87 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 45.4 Cg_endo -71.73 130.07 16.44 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.113 1.876 . . . . 0.0 109.562 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -72.29 118.91 15.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.136 0.494 . . . . 0.0 111.381 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -148.52 151.97 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.276 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.453 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 16.5 mt -93.39 75.58 4.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.976 0.417 . . . . 0.0 111.852 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.519 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 4.6 tmtm? -122.36 122.94 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 9.3 mtpp -65.83 126.2 27.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.962 0.41 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 7.6 p -100.72 139.9 35.76 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.092 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -104.09 1.37 30.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 165.96 164.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.764 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -58.99 -39.15 80.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.073 0.463 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 t -64.17 -19.27 65.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.393 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 47.8 t0 -79.84 -18.01 51.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.78 0.8 . . . . 0.0 109.431 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 76.4 m -88.8 143.17 31.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.24 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 145.82 50.33 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.869 2.379 . . . . 0.0 113.198 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.37 -130.19 50.67 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 36.9 mt-10 -101.2 26.11 7.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.5 m -69.34 144.17 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.5 pt -114.4 156.06 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -79.02 105.66 10.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.9 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 57.2 mtpt -67.28 156.32 36.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.26 47.16 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.776 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 28' ' ' TYR . 11.4 p-10 -74.89 -6.04 47.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 87.18 29.62 22.07 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.268 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 4.3 m-85 -128.32 156.45 43.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.519 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 75.9 m -74.04 127.08 31.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.9 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.931 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.973 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.545 ' HG3' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.2 128.02 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.221 -179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -82.63 133.52 35.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.3 t -157.1 134.43 6.82 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.998 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 61.2 Cg_endo -73.12 -146.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.86 2.373 . . . . 0.0 112.07 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 86.7 mmt-85 -127.84 100.35 5.9 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.96 0.41 . . . . 0.0 110.037 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -151.24 155.58 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.513 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 80.3 mt -118.7 107.98 14.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.096 0.474 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -143.57 126.62 16.41 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.3 mttt -65.67 126.9 29.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.049 0.452 . . . . 0.0 110.508 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.0 p -112.63 145.3 40.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.481 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -99.87 -1.39 37.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.393 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 6.0 ptp85 178.08 164.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.567 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.1 -40.54 94.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.995 0.426 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -65.91 -12.89 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 46.6 t0 -86.23 4.02 40.55 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.007 0.908 . . . . 0.0 109.608 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 97.4 m -111.9 138.76 21.75 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.828 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 145.64 77.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.796 2.331 . . . . 0.0 113.455 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.83 -130.96 50.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.115 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 54.3 mt-10 -100.78 19.23 17.53 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.551 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 99.1 m -65.84 141.36 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -114.12 155.62 15.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.756 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -78.72 100.0 6.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.75 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 1.1 ptpm? -71.01 168.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.742 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -48.62 -40.45 24.89 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -81.12 18.64 1.02 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.346 0.573 . . . . 0.0 112.221 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 64.16 35.49 92.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.756 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.75 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.4 m-85 -125.05 157.73 35.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.363 0.601 . . . . 0.0 110.33 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 62.8 m -81.52 116.84 21.49 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.67 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.922 0 CA-C-O 118.24 -1.311 . . . . 0.0 111.021 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.961 0.41 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.885 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 61.7 mtm180 -74.9 138.64 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.481 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.63 138.78 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 18.6 t -144.59 134.53 11.73 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.3 Cg_endo -71.37 147.42 52.71 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.724 2.283 . . . . 0.0 110.836 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -59.41 114.12 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.103 0.478 . . . . 0.0 110.987 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -146.02 159.56 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.203 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 17.0 mt -128.27 81.55 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 111.021 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.4 125.78 35.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.168 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 7.3 mttm -67.14 117.42 9.15 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 p -91.06 143.88 26.24 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -106.35 -9.03 16.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.425 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 175.02 163.99 0.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.857 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -60.13 -36.03 76.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.719 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.72 -23.02 67.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.232 0.539 . . . . 0.0 110.675 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -79.41 -19.1 50.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.034 0.921 . . . . 0.0 109.307 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 88.3 m -89.89 140.9 27.82 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.596 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.52 143.03 46.03 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.541 2.161 . . . . 0.0 113.442 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 -131.4 46.55 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.505 -0.771 . . . . 0.0 113.629 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.885 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 5.7 mm-40 -89.71 20.01 4.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 84.1 m -73.21 140.01 46.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.543 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.678 HG22 HH21 ' A' ' 2' ' ' ARG . 37.4 pt -112.47 156.53 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.235 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.1 100.21 8.92 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -71.75 153.29 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.199 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.49 -33.66 17.92 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.598 0.561 . . . . 0.0 113.512 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -61.34 -21.12 63.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.851 0.834 . . . . 0.0 110.184 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 93.95 25.74 16.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.828 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 5.7 m-85 -129.26 155.71 45.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 89.1 m -72.8 125.28 27.17 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.705 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.17 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.915 0.388 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -96.05 157.93 15.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.138 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.99 133.02 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.637 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 t -164.99 132.38 2.38 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.233 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.4 Cg_endo -65.98 142.19 67.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.422 2.081 . . . . 0.0 110.132 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -75.05 63.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.464 0.65 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -98.97 153.85 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.71 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -109.83 107.34 17.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.103 0.477 . . . . 0.0 111.412 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -147.46 125.87 12.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.251 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 14.7 mtpp -67.14 131.46 45.84 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.813 0.339 . . . . 0.0 110.375 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.5 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.7 p -109.93 139.59 44.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.125 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 16.5 ptm180 -97.79 -0.83 44.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.431 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 12.2 ptm180 177.98 163.95 0.66 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.51 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -46.78 84.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.0 110.571 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 t -64.81 -11.8 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.56 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 37.8 t0 -82.86 -1.41 51.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.819 0.819 . . . . 0.0 110.14 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.6 m -104.51 141.72 23.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.291 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.76 146.43 48.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.974 2.45 . . . . 0.0 113.596 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -132.39 51.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -96.81 19.7 12.17 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 85.1 m -69.06 139.23 54.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 pt -118.83 154.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.242 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -76.6 104.46 7.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.7 0.762 . . . . 0.0 110.258 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -78.1 156.3 30.06 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.5 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.93 -32.23 8.65 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.49 0.494 . . . . 0.0 113.931 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.538 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -62.59 -16.65 57.46 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.657 0.741 . . . . 0.0 110.941 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.62 22.27 44.04 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.538 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 4.5 m-85 -126.57 158.43 36.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.214 0.531 . . . . 0.0 109.779 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.1 m -77.76 120.8 23.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.56 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.443 -1.198 . . . . 0.0 111.781 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.862 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 99.7 mtt180 -64.06 140.25 58.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.784 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -80.59 134.54 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.373 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 t -153.49 128.66 4.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.13 0.49 . . . . 0.0 111.203 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.0 Cg_endo -77.04 146.89 26.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.815 2.343 . . . . 0.0 110.971 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -61.11 113.91 2.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.83 159.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.652 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.12 82.03 2.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.306 0.574 . . . . 0.0 110.074 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -130.73 128.28 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.664 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.4 mtpt -63.94 124.43 21.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.364 0.415 . . . . 0.0 110.057 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.664 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.3 p -96.81 144.88 26.36 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.981 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -106.49 -13.74 15.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.664 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 175.79 165.14 0.36 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -59.02 -38.47 79.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.874 0.369 . . . . 0.0 110.543 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -20.6 66.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.031 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.65 -15.61 48.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 109.673 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 84.6 m -90.48 140.39 26.82 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.557 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 144.41 61.26 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.518 2.145 . . . . 0.0 112.967 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.99 -130.03 50.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.862 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 53.8 mt-10 -100.18 16.38 24.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.955 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.621 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.8 m -60.45 140.9 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.102 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.453 HG22 ' NH1' ' A' ' 2' ' ' ARG . 35.7 pt -111.28 152.63 13.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.165 0.507 . . . . 0.0 111.166 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.1 96.41 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.811 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -79.31 169.11 18.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 112.449 -177.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.07 -35.59 26.31 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 116.3 1.28 . . . . 0.0 116.3 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.443 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.5 p-10 -77.7 8.8 4.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.995 0.897 . . . . 0.0 111.81 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.33 25.82 73.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.098 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -124.29 158.63 32.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 110.254 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.5 m -80.75 122.64 27.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.876 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.811 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.955 0 CA-C-O 118.257 -1.302 . . . . 0.0 111.453 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 13.2 mmp_? -66.66 134.76 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.5 136.09 40.93 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.004 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -154.08 131.82 6.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.023 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.47 -156.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.898 2.398 . . . . 0.0 111.863 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -94.86 117.53 30.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.13 157.83 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.905 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 18.3 mt -132.43 70.96 1.46 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.384 0.611 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HE2' ' OD2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -118.39 124.92 48.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.67 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -66.78 119.08 11.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.539 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -94.18 142.92 26.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.792 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -114.01 5.32 16.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.0 ptp180 166.96 158.32 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.744 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -58.64 -38.34 77.88 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.217 0.323 . . . . 0.0 111.131 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -63.37 -20.14 65.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.188 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 15.5 t70 -82.53 -12.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.811 0.815 . . . . 0.0 110.19 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 68.1 m -89.98 140.25 27.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.006 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.92 146.31 47.24 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.788 2.325 . . . . 0.0 113.313 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.5 -128.59 47.32 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.305 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 54.4 mt-10 -102.99 18.17 22.32 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.774 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 72.3 m -65.94 142.71 57.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.8 pt -113.77 155.97 14.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.72 99.52 5.12 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.616 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 14.3 mtpp -74.21 151.62 39.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.362 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.03 -25.31 9.88 Favored Glycine 0 C--N 1.339 0.706 0 O-C-N 123.468 0.48 . . . . 0.0 113.25 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 1.2 t-20 -61.87 -23.45 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.066 0.546 . . . . 0.0 110.752 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.43 53.46 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.512 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 3.3 m-85 -120.36 159.42 25.09 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.404 0.621 . . . . 0.0 110.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 94.5 m -73.95 131.48 41.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.485 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.616 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.882 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.546 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.45 0.166 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.79 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 76.1 mtp180 -70.9 135.49 48.01 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.31 133.44 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.4 t -159.63 137.15 7.09 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 120.924 0.392 . . . . 0.0 111.955 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 2.8 Cg_exo -72.3 137.75 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.049 2.499 . . . . 0.0 110.376 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.4 mmt-85 -69.39 118.86 12.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.14 153.89 12.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.423 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 12.4 mt -97.45 66.96 2.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.954 0.407 . . . . 0.0 111.673 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.548 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.93 122.77 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.429 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -67.35 135.26 52.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -118.75 141.4 48.66 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -100.58 -11.26 20.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.906 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.9 ptp180 176.77 165.21 0.49 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.225 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -59.12 -36.71 75.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.715 0.293 . . . . 0.0 110.871 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -63.36 -24.46 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 110.548 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 33.5 t0 -78.59 -17.96 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.025 0.917 . . . . 0.0 109.972 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 74.7 m -88.4 135.94 32.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.62 143.69 63.37 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.652 2.235 . . . . 0.0 113.328 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.05 -131.75 50.33 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.112 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.79 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 46.8 mm-40 -93.96 21.13 6.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 90.7 m -72.79 141.01 48.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.338 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.05 152.81 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.998 0.428 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.2 t -80.51 95.3 6.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -75.15 156.66 35.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.882 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.55 -28.57 5.04 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.529 0.518 . . . . 0.0 114.216 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.525 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 1.3 t-20 -63.07 -16.35 59.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.454 0.645 . . . . 0.0 110.956 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' C ' ' HD1' ' A' ' 28' ' ' TYR . . . 88.8 17.75 55.87 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.625 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -127.26 158.61 36.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.671 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 91.8 m -78.8 120.39 23.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.015 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.502 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-O 118.508 -1.162 . . . . 0.0 111.952 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 121.333 0.587 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . 56.5 mtm-85 -82.73 -177.53 6.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.711 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -71.53 136.61 47.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.974 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -148.47 124.3 5.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 120.997 0.427 . . . . 0.0 111.549 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.676 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 58.7 Cg_endo -71.61 144.63 45.03 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.909 2.406 . . . . 0.0 110.826 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -66.81 102.39 0.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.845 0.355 . . . . 0.0 110.619 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -150.41 154.66 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.824 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.82 111.4 21.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.11 126.12 14.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.2 112.47 5.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.575 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.6 p -87.05 151.47 23.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -127.53 6.38 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 164.78 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.524 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -58.94 -35.41 73.06 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.21 0.319 . . . . 0.0 111.252 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -64.37 -22.65 67.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 111.193 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.76 -12.34 57.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.852 0.834 . . . . 0.0 109.924 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 60.9 m -89.99 137.68 28.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.325 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.87 145.91 76.19 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.846 2.364 . . . . 0.0 112.853 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.29 -126.27 41.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.827 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 52.4 mt-10 -108.97 22.23 16.19 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.782 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 88.2 m -64.76 147.2 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.733 0.301 . . . . 0.0 110.433 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.474 HG22 HH22 ' A' ' 2' ' ' ARG . 37.0 pt -112.01 153.86 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 0.0 110.771 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.1 t -79.35 95.35 5.69 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 5.8 ptmt -79.89 157.49 26.93 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.501 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.54 4.37 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.713 0.633 . . . . 0.0 114.055 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 3.5 t-20 -62.58 -14.18 39.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.564 0.697 . . . . 0.0 110.891 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.14 75.51 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.3 m-85 -121.05 167.88 12.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.565 0.698 . . . . 0.0 110.329 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 96.7 m -81.98 127.71 33.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.879 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 CA-C-O 118.22 -1.322 . . . . 0.0 111.432 179.818 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.762 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 62.9 mtm180 -78.59 155.03 29.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.434 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -68.42 134.53 50.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 0.0 110.642 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -160.88 131.02 3.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.167 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.2 Cg_endo -65.38 153.29 78.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.913 2.409 . . . . 0.0 110.799 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.612 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -77.49 60.85 2.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -96.86 157.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 mt -123.13 105.06 9.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.21 0.528 . . . . 0.0 110.585 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -147.22 130.27 16.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.2 mttt -60.95 127.96 34.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 20.3 p -101.9 141.27 35.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -98.48 -17.67 18.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.503 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.9 ptp180 173.15 166.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.822 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -57.31 -39.24 75.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.88 -24.48 67.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.315 0.578 . . . . 0.0 110.683 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 14.8 t70 -81.73 -15.72 53.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.3 m -89.67 141.85 28.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.597 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.12 144.8 53.21 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.584 2.189 . . . . 0.0 113.204 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.73 -131.55 52.11 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.312 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.762 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 31.6 mt-10 -98.84 21.92 10.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.652 0.263 . . . . 0.0 111.074 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.2 m -67.68 141.36 56.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.29 153.17 14.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.063 0.459 . . . . 0.0 110.602 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.7 t -79.68 96.1 6.13 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.75 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -81.06 156.76 25.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.077 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.81 -27.25 3.16 Favored Glycine 0 N--CA 1.468 0.799 0 O-C-N 123.713 0.633 . . . . 0.0 114.458 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.565 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 1.8 t-20 -62.7 -16.87 59.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.335 0.588 . . . . 0.0 110.878 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 89.34 13.32 61.85 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.565 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 3.9 m-85 -124.91 160.34 29.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.638 0.733 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 68.5 m -77.88 122.15 25.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.569 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.75 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.923 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.699 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.71 0.29 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -70.28 132.32 45.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -78.96 132.09 36.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.687 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.0 t -160.92 129.24 2.92 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.15 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 64.7 Cg_endo -73.56 161.12 42.92 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 111.26 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.7 mmt-85 -80.0 61.19 3.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.395 0.617 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -94.45 155.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.731 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 mt -117.44 105.91 12.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.75 126.37 12.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 48.0 mtpt -63.75 118.94 9.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.7 p -89.17 135.76 33.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.835 0.826 . . . . 0.0 113.174 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.26 -2.17 22.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.294 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 168.64 160.55 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.653 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.11 -41.02 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.84 0.352 . . . . 0.0 110.95 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -64.62 -16.02 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.335 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.19 -17.02 47.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.928 0.871 . . . . 0.0 109.238 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 91.5 m -89.73 140.43 27.98 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.26 146.18 56.38 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.927 2.418 . . . . 0.0 113.366 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.76 -129.09 47.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.288 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 94.5 mt-10 -102.17 23.26 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.575 0.226 . . . . 0.0 110.804 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 91.4 m -68.59 140.7 55.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.68 155.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -77.57 103.35 7.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.797 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -84.1 170.3 13.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.962 -179.12 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.83 -34.48 29.75 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 116.333 1.293 . . . . 0.0 116.333 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.4 p-10 -78.47 8.59 4.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.102 0.951 . . . . 0.0 111.888 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.19 26.45 72.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.992 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.552 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m-85 -125.64 156.88 38.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 110.374 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.4 m -77.77 120.21 22.36 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.797 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.685 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.635 ' HG3' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -67.42 126.34 28.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.209 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.97 135.01 33.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.433 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.0 t -157.3 131.23 4.88 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.984 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.7 Cg_endo -76.17 163.26 33.04 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.719 2.279 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 6' ' ' ARG . 37.8 tpt85 -74.26 66.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.341 0.591 . . . . 0.0 110.713 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -88.86 156.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 10.9 mt -121.72 64.56 0.9 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.38 124.63 52.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.526 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.93 122.59 17.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 12.9 p -96.94 138.98 33.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.491 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 15.1 ptm180 -110.28 -1.34 17.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.16 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HG2' ' HG3' ' A' ' 12' ' ' ARG . 16.8 ptm180 172.63 157.47 0.1 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.009 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -58.2 -39.02 77.9 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 123.458 0.473 . . . . 0.0 111.085 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -62.73 -20.57 65.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.497 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.491 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 44.7 t0 -80.99 -15.29 56.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.932 0.872 . . . . 0.0 109.728 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 87.4 m -89.94 139.81 27.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.016 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.42 146.23 39.41 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.839 2.359 . . . . 0.0 113.476 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.01 -129.97 48.7 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.464 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 55.3 mt-10 -98.7 19.07 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.5 m -67.21 137.63 56.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.158 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 pt -115.83 156.14 16.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -77.03 100.96 5.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.701 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -80.23 153.85 28.28 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.338 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.25 3.96 Favored Glycine 0 N--CA 1.468 0.781 0 O-C-N 123.546 0.529 . . . . 0.0 114.108 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.513 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 1.9 t-20 -61.39 -20.23 62.8 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.887 0.475 . . . . 0.0 111.043 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.79 9.06 57.76 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.85 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.2 m-85 -123.95 163.45 21.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.565 0.698 . . . . 0.0 110.401 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 93.6 m -75.72 127.55 33.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.701 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.951 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.035 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.973 0.416 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.626 HH11 HG21 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -117.01 135.76 53.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -95.53 138.39 33.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.462 . . . . 0.0 111.56 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 51.9 t -151.26 134.34 8.86 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.94 -151.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.901 2.401 . . . . 0.0 112.431 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -94.61 113.4 25.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.64 156.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.8 mt -133.1 68.52 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.463 0.649 . . . . 0.0 110.745 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.38 125.24 52.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -64.11 118.32 8.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.41 136.21 33.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.028 0.918 . . . . 0.0 113.383 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -106.08 -6.12 18.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.336 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 167.03 158.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.74 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.55 -43.78 72.3 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.44 0.463 . . . . 0.0 111.166 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 m -63.0 -20.67 65.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.999 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -83.78 -10.29 58.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.848 0.832 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.4 m -92.38 143.55 27.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 143.55 43.95 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.617 2.211 . . . . 0.0 113.278 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.32 -128.55 47.5 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.605 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 36.7 mt-10 -96.9 10.0 40.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.326 0.108 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.3 m -62.65 138.64 58.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 110.364 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.626 HG21 HH11 ' A' ' 2' ' ' ARG . 31.7 pt -115.43 163.84 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.817 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.29 98.39 8.12 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.696 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -79.48 153.95 29.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.384 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.67 -28.12 4.98 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 123.537 0.523 . . . . 0.0 114.106 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 2.0 t-20 -61.13 -20.24 62.44 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.929 0.492 . . . . 0.0 111.207 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.7 9.37 57.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.827 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.627 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.4 m-85 -123.1 165.61 16.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.511 0.672 . . . . 0.0 110.331 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -77.6 128.63 34.45 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.065 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.696 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.11 0 CA-C-O 118.171 -1.349 . . . . 0.0 111.143 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.804 0.335 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.74 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 38.8 mmt180 -69.78 139.15 53.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.685 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -80.45 134.31 35.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 t -156.05 131.11 5.25 Favored Pre-proline 0 C--N 1.319 -0.717 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.619 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.5 Cg_endo -71.57 152.67 59.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.681 2.254 . . . . 0.0 111.39 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -73.92 65.47 1.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.413 0.625 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 8' ' ' LEU . 10.2 tp -105.76 165.79 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.864 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 7' ' ' ILE . 54.2 mt -128.35 105.08 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.223 0.535 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.3 tmtm? -147.09 129.57 15.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.911 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -68.01 130.74 43.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 7.5 p -110.25 149.03 30.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.583 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -113.04 2.28 15.66 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 170.5 162.52 0.07 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.776 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.38 -35.31 71.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.884 0.373 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -62.21 -25.46 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.078 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 51.8 t0 -76.72 -18.97 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.799 0.809 . . . . 0.0 109.492 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 92.6 m -88.89 138.07 29.54 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.843 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 146.65 41.3 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.855 2.37 . . . . 0.0 113.259 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.28 -130.4 48.81 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.334 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 51.9 mt-10 -99.52 18.13 18.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.796 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.16 139.04 58.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -113.2 154.63 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.276 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -78.74 98.95 6.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -75.95 155.52 35.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.389 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.17 -30.95 5.82 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 123.546 0.529 . . . . 0.0 114.102 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 1.3 t-20 -61.54 -17.77 56.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.437 0.637 . . . . 0.0 111.122 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.64 13.11 58.65 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.852 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.64 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.8 m-85 -120.11 162.58 19.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.162 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.9 m -80.13 125.31 29.66 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.31 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.44 -1.083 0 CA-C-O 118.283 -1.287 . . . . 0.0 111.017 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.306 0.574 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.61 147.74 50.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.1 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.559 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -81.63 139.08 35.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.109 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.1 t -158.45 131.18 4.44 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 121.002 0.43 . . . . 0.0 111.382 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 59.0 Cg_endo -71.76 153.8 59.07 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.947 2.431 . . . . 0.0 110.772 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -70.32 114.17 8.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.098 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 tt -150.17 156.92 6.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.386 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.4 83.73 2.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.443 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -129.51 126.13 37.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.0 mtpm? -64.41 124.26 21.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.6 p -92.99 142.93 26.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.016 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -106.0 -8.61 17.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' ' 16' ' ' ASP . 22.2 ptt180 175.57 165.69 0.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.406 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -61.29 -42.41 98.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -68.87 -5.67 22.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 37.6 t70 -91.8 -13.41 31.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.733 . . . . 0.0 109.22 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 90.7 m -89.9 143.6 30.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.995 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.98 145.6 80.18 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.749 2.299 . . . . 0.0 112.824 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.57 -126.67 42.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.991 -0.624 . . . . 0.0 111.948 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 7.1 pt-20 -109.13 22.45 15.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.697 0.284 . . . . 0.0 110.541 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.4 m -65.13 150.57 47.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.123 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.9 pt -116.88 158.26 17.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 111.51 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 t -82.36 97.31 8.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.581 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -71.19 153.22 42.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.345 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.97 -32.37 6.15 Favored Glycine 0 N--CA 1.468 0.831 0 O-C-N 123.547 0.529 . . . . 0.0 114.129 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -61.39 -19.45 61.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.402 0.62 . . . . 0.0 110.992 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 18.87 36.06 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.022 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.676 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.7 m-85 -123.8 161.42 25.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.261 0.553 . . . . 0.0 110.007 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 64.5 m -80.65 125.23 29.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.066 0 CA-C-O 118.36 -1.244 . . . . 0.0 111.156 179.432 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.0 0.429 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.565 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 1.1 mpp_? -62.67 138.56 58.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -85.12 144.21 28.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.826 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 45.7 t -159.21 135.67 6.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.373 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 88.0 Cg_endo -78.75 -145.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.762 2.308 . . . . 0.0 111.673 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 51.4 mmm-85 -110.99 118.35 35.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.52 154.91 8.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.3 mt -117.47 64.45 0.73 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.148 0.499 . . . . 0.0 111.288 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -110.24 121.54 45.51 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 111.34 4.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.526 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.5 p -87.34 150.7 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -122.66 1.9 9.48 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 166.38 158.1 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.73 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.67 -39.02 73.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.492 0.495 . . . . 0.0 111.202 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -61.77 -23.08 65.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.345 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.48 -9.46 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.833 0.825 . . . . 0.0 109.906 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.9 m -93.41 142.67 25.53 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.03 144.05 80.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.803 2.335 . . . . 0.0 112.682 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.86 -125.25 38.55 Favored Glycine 0 CA--C 1.509 -0.327 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 2' ' ' ARG . 10.9 pt-20 -112.44 26.5 10.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.884 0.374 . . . . 0.0 110.054 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.6 m -63.57 148.11 49.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.775 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 30' ' ' GLY . 23.0 pt -112.18 155.45 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.308 0.575 . . . . 0.0 111.71 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.34 97.51 7.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -80.0 158.01 26.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.923 -178.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.93 3.88 Favored Glycine 0 N--CA 1.468 0.812 0 O-C-N 123.546 0.529 . . . . 0.0 114.003 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.561 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 3.9 t-20 -62.41 -14.76 44.02 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.441 0.638 . . . . 0.0 110.964 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.14 74.96 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.53 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.2 m-85 -122.83 166.76 14.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.387 0.613 . . . . 0.0 110.129 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 92.6 m -78.48 126.94 31.46 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.0 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.484 ' O ' HG12 ' A' ' 22' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-O 118.256 -1.302 . . . . 0.0 110.98 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.551 ' NE ' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.1 126.16 27.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.296 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.26 137.63 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.218 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 1.6 t -167.76 126.22 0.99 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.767 0.318 . . . . 0.0 111.785 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 49.5 Cg_endo -68.44 137.55 39.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.711 2.274 . . . . 0.0 110.161 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.707 ' NH1' ' HA2' ' A' ' 30' ' ' GLY . 1.2 tpp180 -76.25 119.57 20.34 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.429 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -149.77 151.79 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.985 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.67 72.88 1.57 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 3.1 tmtm? -118.58 127.48 53.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.737 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.82 123.29 19.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . 28.4 p -102.28 146.04 28.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.958 0.885 . . . . 0.0 113.303 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.5 mmp_? -114.46 -9.72 12.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.068 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 7.0 ptp85 178.64 161.07 0.65 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.1 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 -39.54 81.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.812 0.339 . . . . 0.0 110.804 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' A' ' 11' ' ' CYS . 3.5 t70 -84.89 -15.81 43.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.812 0.815 . . . . 0.0 109.285 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 40.1 m -87.8 144.39 34.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.378 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.93 143.27 59.96 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.484 2.123 . . . . 0.0 112.834 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.21 -126.57 42.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.859 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.551 ' HB3' ' NE ' ' A' ' 2' ' ' ARG . 3.4 mt-10 -107.17 27.62 8.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.782 0.325 . . . . 0.0 111.043 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.2 m -70.13 148.13 49.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.61 152.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.0 110.902 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -81.84 102.0 10.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.168 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 6.5 ptmt -87.78 158.89 18.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.651 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.34 -26.71 3.59 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.8 0.688 . . . . 0.0 114.058 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.495 ' OD1' ' HB2' ' A' ' 28' ' ' TYR . 4.4 t-20 -61.17 -17.04 50.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.446 0.641 . . . . 0.0 110.807 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.71 69.2 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.538 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.1 m-85 -126.09 165.83 18.12 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.664 0.745 . . . . 0.0 110.385 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 98.9 m -78.43 122.85 26.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.841 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.707 ' HA2' ' NH1' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.44 -1.097 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.962 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 140.05 55.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.026 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -85.94 134.15 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.6 t -145.01 124.52 6.99 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.968 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.6 Cg_endo -70.39 154.96 64.81 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.126 2.55 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -66.17 96.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.491 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.49 153.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.954 0.407 . . . . 0.0 110.49 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -146.39 130.98 17.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -61.22 128.04 34.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.989 0.423 . . . . 0.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 21.5 p -92.65 142.58 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.504 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -107.13 -14.75 14.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.469 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 174.97 161.35 0.21 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.479 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -56.06 -45.64 79.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.004 0.431 . . . . 0.0 111.074 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.6 t -65.65 -17.07 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.449 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -13.69 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.656 0.741 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.0 m -88.66 143.59 32.16 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 144.33 58.21 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.797 2.331 . . . . 0.0 113.32 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.56 -128.96 48.05 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 91.0 mt-10 -101.23 17.5 22.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.501 0.191 . . . . 0.0 110.563 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.693 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 87.3 m -67.25 140.86 57.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -115.61 159.18 15.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.59 97.02 5.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.754 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 5.7 ptmt -77.31 156.34 31.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.957 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.24 -30.83 5.91 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 123.53 0.519 . . . . 0.0 114.142 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 1.5 t-20 -62.01 -16.59 52.74 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.604 0.716 . . . . 0.0 110.963 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.88 22.42 46.02 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.501 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 4.0 m-85 -128.67 164.1 23.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.5 m -79.99 125.22 29.49 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.806 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.543 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.662 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.076 0.465 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 21.1 mmm180 -107.25 179.16 4.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.509 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -77.65 134.37 38.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.014 0.435 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.4 t -155.28 128.15 4.2 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.3 Cg_endo -71.31 146.11 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.685 2.257 . . . . 0.0 111.196 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -66.44 101.42 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.943 0.401 . . . . 0.0 110.772 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.42 152.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.45 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.12 108.1 16.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.8 tmtm? -146.06 129.69 17.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.483 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.06 131.77 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -117.26 139.81 50.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.356 0.598 . . . . 0.0 111.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -101.94 0.2 34.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 177.66 163.02 0.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.909 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -60.27 -38.04 82.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.736 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -63.72 -18.78 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.01 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.587 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 50.8 t0 -78.87 -18.52 53.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.0 m -88.44 140.96 30.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.345 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.29 145.77 30.87 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.751 2.301 . . . . 0.0 113.444 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.23 -130.5 49.03 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.52 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 94.3 mt-10 -97.62 16.13 21.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.994 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.3 139.72 58.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.93 154.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.887 0.375 . . . . 0.0 110.269 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -80.55 99.68 8.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -76.51 154.54 34.53 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.314 -179.378 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.58 -27.65 4.52 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 123.537 0.523 . . . . 0.0 114.14 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.524 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 1.7 t-20 -62.33 -18.28 61.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.81 9.0 60.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.761 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.634 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.0 m-85 -121.27 163.14 19.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.562 0.696 . . . . 0.0 110.732 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 68.4 m -78.02 126.06 30.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.387 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.556 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.92 0 CA-C-O 118.272 -1.294 . . . . 0.0 111.161 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 132.68 54.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.582 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.85 137.49 53.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.748 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.405 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 49.4 t -154.18 137.53 10.43 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 48.9 Cg_endo -68.39 163.42 36.57 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.682 2.254 . . . . 0.0 111.229 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -75.54 63.61 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.189 0.519 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.85 155.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 73.12 1.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.247 0.546 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -122.35 126.1 47.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.361 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.5 mtpm? -62.66 126.62 27.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.046 0.451 . . . . 0.0 110.35 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.533 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 8.4 p -95.47 141.53 28.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.169 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.65 -13.86 22.52 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.2 ptp180 170.54 164.87 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.452 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.79 -41.11 77.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.741 0.305 . . . . 0.0 111.159 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -64.36 -21.79 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.187 0.518 . . . . 0.0 111.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 16.0 t70 -82.14 -13.34 57.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.76 0.79 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.3 m -89.54 140.8 28.32 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.0 143.1 64.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.874 2.383 . . . . 0.0 113.25 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.25 -131.54 42.0 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 113.725 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -93.32 24.86 3.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 94.9 m -77.99 143.35 37.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 30' ' ' GLY . 35.7 pt -114.16 160.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.837 0.351 . . . . 0.0 110.482 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 t -83.06 97.8 8.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.694 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 2.8 ptmm? -74.68 166.6 23.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.213 0.53 . . . . 0.0 112.266 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.45 -37.67 26.15 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.178 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.694 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -79.52 16.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.761 0.78 . . . . 0.0 112.022 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 63.33 32.99 86.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.896 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.595 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -126.48 162.63 25.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 58.3 m -82.08 121.85 27.09 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.107 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.035 -1.425 . . . . 0.0 111.149 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.894 0.378 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -67.98 146.99 53.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.29 139.19 8.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 17.1 t -144.93 136.16 12.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.859 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.05 -149.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.789 2.326 . . . . 0.0 111.958 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -90.45 102.63 15.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.25 154.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -135.67 104.5 5.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.66 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.35 125.25 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.6 mtpt -66.43 119.11 11.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -97.22 135.84 38.58 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 13.6 ptm180 -102.4 6.46 40.23 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 165.76 157.79 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.49 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.73 -33.28 72.66 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.242 0.339 . . . . 0.0 110.929 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 42.2 t0 -82.17 -9.53 59.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.779 0.799 . . . . 0.0 110.069 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 93.5 m -89.97 137.97 27.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.317 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.56 144.99 46.11 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.852 2.368 . . . . 0.0 113.261 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.86 -131.36 47.54 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.419 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.5 22.37 6.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 72.7 m -76.67 142.82 40.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.443 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -113.82 159.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.76 97.34 8.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.605 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 3.0 ptpt -75.48 153.01 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.757 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.2 -28.88 4.6 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 123.665 0.603 . . . . 0.0 114.198 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.605 ' HB3' ' HG3' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -61.41 -21.15 63.83 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.164 0.507 . . . . 0.0 111.151 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 98.28 9.96 52.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.71 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.4 m-85 -122.0 157.76 30.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.703 0.764 . . . . 0.0 110.871 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 72.7 m -77.74 126.64 31.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.461 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 45.4 Cg_endo -71.73 130.07 16.44 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.113 1.876 . . . . 0.0 109.562 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -72.29 118.91 15.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.136 0.494 . . . . 0.0 111.381 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -148.52 151.97 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.276 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.453 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 16.5 mt -93.39 75.58 4.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.976 0.417 . . . . 0.0 111.852 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.519 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 4.6 tmtm? -122.36 122.94 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 9.3 mtpp -65.83 126.2 27.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.962 0.41 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 7.6 p -100.72 139.9 35.76 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.092 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -104.09 1.37 30.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 165.96 164.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.764 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -58.99 -39.15 80.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.073 0.463 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 t -64.17 -19.27 65.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.393 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 47.8 t0 -79.84 -18.01 51.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.78 0.8 . . . . 0.0 109.431 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 76.4 m -88.8 143.17 31.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.24 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 145.82 50.33 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.869 2.379 . . . . 0.0 113.198 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.37 -130.19 50.67 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.2 26.11 7.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.5 m -69.34 144.17 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.5 pt -114.4 156.06 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -79.02 105.66 10.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.9 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 57.2 mtpt -67.28 156.32 36.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.26 47.16 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.776 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 28' ' ' TYR . 11.4 p-10 -74.89 -6.04 47.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 87.18 29.62 22.07 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.268 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 4.3 m-85 -128.32 156.45 43.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.519 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 75.9 m -74.04 127.08 31.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.9 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.931 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.973 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.236 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 61.2 Cg_endo -73.12 -146.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.86 2.373 . . . . 0.0 112.07 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.48 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 86.7 mmt-85 -127.84 100.35 5.9 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.96 0.41 . . . . 0.0 110.037 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -151.24 155.58 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.513 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 80.3 mt -118.7 107.98 14.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.096 0.474 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -143.57 126.62 16.41 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.3 mttt -65.67 126.9 29.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.049 0.452 . . . . 0.0 110.508 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.0 p -112.63 145.3 40.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.481 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -99.87 -1.39 37.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.393 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 6.0 ptp85 178.08 164.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.567 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.1 -40.54 94.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.995 0.426 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -65.91 -12.89 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 46.6 t0 -86.23 4.02 40.55 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.007 0.908 . . . . 0.0 109.608 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 97.4 m -111.9 138.76 21.75 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.828 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 145.64 77.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.796 2.331 . . . . 0.0 113.455 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.83 -130.96 50.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.115 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -100.78 19.23 17.53 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.551 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 99.1 m -65.84 141.36 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -114.12 155.62 15.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.756 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -78.72 100.0 6.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.75 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 1.1 ptpm? -71.01 168.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.742 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -48.62 -40.45 24.89 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -81.12 18.64 1.02 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.346 0.573 . . . . 0.0 112.221 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 64.16 35.49 92.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.756 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.75 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.4 m-85 -125.05 157.73 35.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.363 0.601 . . . . 0.0 110.33 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 62.8 m -81.52 116.84 21.49 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.67 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.922 0 CA-C-O 118.24 -1.311 . . . . 0.0 111.021 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 18.6 t . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.3 Cg_endo -71.37 147.42 52.71 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.724 2.283 . . . . 0.0 110.836 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -59.41 114.12 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.103 0.478 . . . . 0.0 110.987 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -146.02 159.56 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.203 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 17.0 mt -128.27 81.55 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 111.021 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.4 125.78 35.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.168 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 7.3 mttm -67.14 117.42 9.15 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 p -91.06 143.88 26.24 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -106.35 -9.03 16.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.425 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 175.02 163.99 0.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.857 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -60.13 -36.03 76.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.719 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.72 -23.02 67.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.232 0.539 . . . . 0.0 110.675 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -79.41 -19.1 50.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.034 0.921 . . . . 0.0 109.307 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 88.3 m -89.89 140.9 27.82 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.596 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.52 143.03 46.03 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.541 2.161 . . . . 0.0 113.442 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 -131.4 46.55 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.505 -0.771 . . . . 0.0 113.629 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.71 20.01 4.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 84.1 m -73.21 140.01 46.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.543 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.4 pt -112.47 156.53 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.235 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.1 100.21 8.92 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -71.75 153.29 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.199 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.49 -33.66 17.92 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.598 0.561 . . . . 0.0 113.512 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.627 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -61.34 -21.12 63.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.851 0.834 . . . . 0.0 110.184 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 93.95 25.74 16.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.828 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.627 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 5.7 m-85 -129.26 155.71 45.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 89.1 m -72.8 125.28 27.17 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.705 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.17 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.687 0.28 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.4 Cg_endo -65.98 142.19 67.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.422 2.081 . . . . 0.0 110.132 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -75.05 63.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.464 0.65 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -98.97 153.85 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.71 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -109.83 107.34 17.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.103 0.477 . . . . 0.0 111.412 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -147.46 125.87 12.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.251 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 14.7 mtpp -67.14 131.46 45.84 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.813 0.339 . . . . 0.0 110.375 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.5 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.7 p -109.93 139.59 44.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.125 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.427 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 16.5 ptm180 -97.79 -0.83 44.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.431 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 12.2 ptm180 177.98 163.95 0.66 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.51 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -46.78 84.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.0 110.571 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 t -64.81 -11.8 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.56 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 37.8 t0 -82.86 -1.41 51.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.819 0.819 . . . . 0.0 110.14 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.6 m -104.51 141.72 23.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.291 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.76 146.43 48.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.974 2.45 . . . . 0.0 113.596 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -132.39 51.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -96.81 19.7 12.17 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 85.1 m -69.06 139.23 54.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 pt -118.83 154.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.242 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -76.6 104.46 7.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.7 0.762 . . . . 0.0 110.258 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -78.1 156.3 30.06 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.5 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.93 -32.23 8.65 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.49 0.494 . . . . 0.0 113.931 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.69 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -62.59 -16.65 57.46 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.657 0.741 . . . . 0.0 110.941 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.62 22.27 44.04 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.69 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.5 m-85 -126.57 158.43 36.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.214 0.531 . . . . 0.0 109.779 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.1 m -77.76 120.8 23.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.56 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.443 -1.198 . . . . 0.0 111.781 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 121.13 0.49 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.0 Cg_endo -77.04 146.89 26.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.815 2.343 . . . . 0.0 110.971 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -61.11 113.91 2.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.83 159.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.652 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.12 82.03 2.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.306 0.574 . . . . 0.0 110.074 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -130.73 128.28 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.664 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.4 mtpt -63.94 124.43 21.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.364 0.415 . . . . 0.0 110.057 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.664 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.3 p -96.81 144.88 26.36 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.981 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -106.49 -13.74 15.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.664 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 175.79 165.14 0.36 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -59.02 -38.47 79.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.874 0.369 . . . . 0.0 110.543 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -20.6 66.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.031 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.65 -15.61 48.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 109.673 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 84.6 m -90.48 140.39 26.82 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.557 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 144.41 61.26 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.518 2.145 . . . . 0.0 112.967 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.99 -130.03 50.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.18 16.38 24.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.955 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.621 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.8 m -60.45 140.9 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.102 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.7 pt -111.28 152.63 13.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.165 0.507 . . . . 0.0 111.166 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.1 96.41 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.811 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -79.31 169.11 18.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 112.449 -177.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.07 -35.59 26.31 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 116.3 1.28 . . . . 0.0 116.3 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.443 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.5 p-10 -77.7 8.8 4.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.995 0.897 . . . . 0.0 111.81 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.33 25.82 73.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.098 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -124.29 158.63 32.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 110.254 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.5 m -80.75 122.64 27.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.876 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.811 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.955 0 CA-C-O 118.257 -1.302 . . . . 0.0 111.453 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.47 -156.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.898 2.398 . . . . 0.0 111.863 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -94.86 117.53 30.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.13 157.83 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.905 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 18.3 mt -132.43 70.96 1.46 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.384 0.611 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HE2' ' OD2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -118.39 124.92 48.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.67 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -66.78 119.08 11.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.539 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -94.18 142.92 26.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.792 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -114.01 5.32 16.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.0 ptp180 166.96 158.32 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.744 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -58.64 -38.34 77.88 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.217 0.323 . . . . 0.0 111.131 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -63.37 -20.14 65.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.188 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 15.5 t70 -82.53 -12.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.811 0.815 . . . . 0.0 110.19 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 68.1 m -89.98 140.25 27.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.006 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.92 146.31 47.24 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.788 2.325 . . . . 0.0 113.313 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.5 -128.59 47.32 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.305 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -102.99 18.17 22.32 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 72.3 m -65.94 142.71 57.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.8 pt -113.77 155.97 14.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.72 99.52 5.12 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.616 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 14.3 mtpp -74.21 151.62 39.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.362 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.03 -25.31 9.88 Favored Glycine 0 C--N 1.339 0.706 0 O-C-N 123.468 0.48 . . . . 0.0 113.25 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.665 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.3 t30 -61.87 -23.45 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.066 0.546 . . . . 0.0 110.752 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.43 53.46 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.665 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.3 m-85 -120.36 159.42 25.09 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.404 0.621 . . . . 0.0 110.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 94.5 m -73.95 131.48 41.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.485 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.616 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.882 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.546 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.4 t . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 2.8 Cg_exo -72.3 137.75 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.049 2.499 . . . . 0.0 110.376 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.4 mmt-85 -69.39 118.86 12.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.14 153.89 12.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.423 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 12.4 mt -97.45 66.96 2.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.954 0.407 . . . . 0.0 111.673 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.548 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.93 122.77 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.429 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -67.35 135.26 52.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -118.75 141.4 48.66 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -100.58 -11.26 20.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.906 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.9 ptp180 176.77 165.21 0.49 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.225 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -59.12 -36.71 75.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.715 0.293 . . . . 0.0 110.871 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -63.36 -24.46 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 110.548 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 33.5 t0 -78.59 -17.96 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.025 0.917 . . . . 0.0 109.972 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 74.7 m -88.4 135.94 32.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.62 143.69 63.37 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.652 2.235 . . . . 0.0 113.328 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.05 -131.75 50.33 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.112 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -93.96 21.13 6.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 90.7 m -72.79 141.01 48.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.338 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.05 152.81 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.998 0.428 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.2 t -80.51 95.3 6.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -75.15 156.66 35.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.882 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.55 -28.57 5.04 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.529 0.518 . . . . 0.0 114.216 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.4 t30 -63.07 -16.35 59.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.454 0.645 . . . . 0.0 110.956 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' C ' ' HD1' ' A' ' 28' ' ' TYR . . . 88.8 17.75 55.87 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.675 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.3 m-85 -127.26 158.61 36.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.671 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 91.8 m -78.8 120.39 23.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.015 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.502 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-O 118.508 -1.162 . . . . 0.0 111.952 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.676 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 58.7 Cg_endo -71.61 144.63 45.03 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.909 2.406 . . . . 0.0 110.826 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -66.81 102.39 0.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.845 0.355 . . . . 0.0 110.619 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -150.41 154.66 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.824 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.82 111.4 21.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.11 126.12 14.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.2 112.47 5.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.575 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.6 p -87.05 151.47 23.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -127.53 6.38 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 164.78 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.524 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -58.94 -35.41 73.06 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.21 0.319 . . . . 0.0 111.252 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -64.37 -22.65 67.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 111.193 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.76 -12.34 57.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.852 0.834 . . . . 0.0 109.924 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 60.9 m -89.99 137.68 28.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.325 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.87 145.91 76.19 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.846 2.364 . . . . 0.0 112.853 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.29 -126.27 41.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.827 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -108.97 22.23 16.19 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.782 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 88.2 m -64.76 147.2 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.733 0.301 . . . . 0.0 110.433 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 pt -112.01 153.86 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 0.0 110.771 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.1 t -79.35 95.35 5.69 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 5.8 ptmt -79.89 157.49 26.93 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.501 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.54 4.37 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.713 0.633 . . . . 0.0 114.055 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.646 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 5.2 t30 -62.58 -14.18 39.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.564 0.697 . . . . 0.0 110.891 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.14 75.51 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.3 m-85 -121.05 167.88 12.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.565 0.698 . . . . 0.0 110.329 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 96.7 m -81.98 127.71 33.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.879 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 CA-C-O 118.22 -1.322 . . . . 0.0 111.432 179.818 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.236 0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.2 Cg_endo -65.38 153.29 78.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.913 2.409 . . . . 0.0 110.799 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.612 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -77.49 60.85 2.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -96.86 157.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 mt -123.13 105.06 9.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.21 0.528 . . . . 0.0 110.585 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -147.22 130.27 16.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.2 mttt -60.95 127.96 34.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 20.3 p -101.9 141.27 35.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -98.48 -17.67 18.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.503 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.9 ptp180 173.15 166.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.822 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -57.31 -39.24 75.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.88 -24.48 67.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.315 0.578 . . . . 0.0 110.683 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 14.8 t70 -81.73 -15.72 53.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.3 m -89.67 141.85 28.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.597 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.12 144.8 53.21 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.584 2.189 . . . . 0.0 113.204 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.73 -131.55 52.11 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.312 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -98.84 21.92 10.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.652 0.263 . . . . 0.0 111.074 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.2 m -67.68 141.36 56.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.29 153.17 14.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.063 0.459 . . . . 0.0 110.602 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.7 t -79.68 96.1 6.13 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.75 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -81.06 156.76 25.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.077 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.81 -27.25 3.16 Favored Glycine 0 N--CA 1.468 0.799 0 O-C-N 123.713 0.633 . . . . 0.0 114.458 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.715 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 2.2 t30 -62.7 -16.87 59.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.335 0.588 . . . . 0.0 110.878 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 89.34 13.32 61.85 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.715 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.9 m-85 -124.91 160.34 29.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.638 0.733 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 68.5 m -77.88 122.15 25.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.569 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.75 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.923 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.699 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 64.7 Cg_endo -73.56 161.12 42.92 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 111.26 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.7 mmt-85 -80.0 61.19 3.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.395 0.617 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -94.45 155.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.731 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 mt -117.44 105.91 12.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.75 126.37 12.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 48.0 mtpt -63.75 118.94 9.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.7 p -89.17 135.76 33.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.835 0.826 . . . . 0.0 113.174 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.26 -2.17 22.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.294 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 168.64 160.55 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.653 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.11 -41.02 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.84 0.352 . . . . 0.0 110.95 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -64.62 -16.02 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.335 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.19 -17.02 47.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.928 0.871 . . . . 0.0 109.238 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 91.5 m -89.73 140.43 27.98 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.26 146.18 56.38 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.927 2.418 . . . . 0.0 113.366 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.76 -129.09 47.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.288 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -102.17 23.26 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.575 0.226 . . . . 0.0 110.804 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 91.4 m -68.59 140.7 55.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.68 155.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -77.57 103.35 7.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.797 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -84.1 170.3 13.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.962 -179.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.83 -34.48 29.75 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 116.333 1.293 . . . . 0.0 116.333 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.4 p-10 -78.47 8.59 4.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.102 0.951 . . . . 0.0 111.888 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.19 26.45 72.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.992 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.552 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m-85 -125.64 156.88 38.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 110.374 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.4 m -77.77 120.21 22.36 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.797 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.685 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.433 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.0 t . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.7 Cg_endo -76.17 163.26 33.04 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.719 2.279 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 6' ' ' ARG . 37.8 tpt85 -74.26 66.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.341 0.591 . . . . 0.0 110.713 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -88.86 156.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 10.9 mt -121.72 64.56 0.9 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.38 124.63 52.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.526 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.93 122.59 17.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 12.9 p -96.94 138.98 33.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.491 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 15.1 ptm180 -110.28 -1.34 17.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.16 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HG2' ' HG3' ' A' ' 12' ' ' ARG . 16.8 ptm180 172.63 157.47 0.1 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.009 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -58.2 -39.02 77.9 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 123.458 0.473 . . . . 0.0 111.085 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -62.73 -20.57 65.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.497 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.491 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 44.7 t0 -80.99 -15.29 56.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.932 0.872 . . . . 0.0 109.728 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 87.4 m -89.94 139.81 27.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.016 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.42 146.23 39.41 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.839 2.359 . . . . 0.0 113.476 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.01 -129.97 48.7 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.464 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -98.7 19.07 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.74 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.5 m -67.21 137.63 56.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.158 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 pt -115.83 156.14 16.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -77.03 100.96 5.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.701 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -80.23 153.85 28.28 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.338 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.25 3.96 Favored Glycine 0 N--CA 1.468 0.781 0 O-C-N 123.546 0.529 . . . . 0.0 114.108 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.616 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.9 t30 -61.39 -20.23 62.8 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.887 0.475 . . . . 0.0 111.043 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.79 9.06 57.76 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.85 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.2 m-85 -123.95 163.45 21.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.565 0.698 . . . . 0.0 110.401 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 93.6 m -75.72 127.55 33.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.701 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.951 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.035 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 51.9 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.94 -151.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.901 2.401 . . . . 0.0 112.431 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -94.61 113.4 25.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.64 156.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.8 mt -133.1 68.52 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.463 0.649 . . . . 0.0 110.745 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.38 125.24 52.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -64.11 118.32 8.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.41 136.21 33.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.028 0.918 . . . . 0.0 113.383 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -106.08 -6.12 18.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.336 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 167.03 158.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.74 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.55 -43.78 72.3 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.44 0.463 . . . . 0.0 111.166 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 m -63.0 -20.67 65.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.999 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -83.78 -10.29 58.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.848 0.832 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.4 m -92.38 143.55 27.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 143.55 43.95 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.617 2.211 . . . . 0.0 113.278 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.32 -128.55 47.5 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.605 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -96.9 10.0 40.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.326 0.108 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.3 m -62.65 138.64 58.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 110.364 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.43 163.84 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.817 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.29 98.39 8.12 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.696 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -79.48 153.95 29.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.384 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.67 -28.12 4.98 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 123.537 0.523 . . . . 0.0 114.106 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 2.0 t30 -61.13 -20.24 62.44 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.929 0.492 . . . . 0.0 111.207 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.7 9.37 57.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.827 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.627 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.4 m-85 -123.1 165.61 16.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.511 0.672 . . . . 0.0 110.331 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -77.6 128.63 34.45 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.065 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.696 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.11 0 CA-C-O 118.171 -1.349 . . . . 0.0 111.143 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.59 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.5 Cg_endo -71.57 152.67 59.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.681 2.254 . . . . 0.0 111.39 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -73.92 65.47 1.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.413 0.625 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 8' ' ' LEU . 10.2 tp -105.76 165.79 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.864 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 7' ' ' ILE . 54.2 mt -128.35 105.08 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.223 0.535 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.3 tmtm? -147.09 129.57 15.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.911 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -68.01 130.74 43.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 7.5 p -110.25 149.03 30.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.583 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -113.04 2.28 15.66 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 170.5 162.52 0.07 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.776 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.38 -35.31 71.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.884 0.373 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -62.21 -25.46 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.078 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 51.8 t0 -76.72 -18.97 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.799 0.809 . . . . 0.0 109.492 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 92.6 m -88.89 138.07 29.54 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.843 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 146.65 41.3 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.855 2.37 . . . . 0.0 113.259 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.28 -130.4 48.81 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.334 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.52 18.13 18.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.796 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.16 139.04 58.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -113.2 154.63 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.276 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -78.74 98.95 6.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -75.95 155.52 35.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.389 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.17 -30.95 5.82 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 123.546 0.529 . . . . 0.0 114.102 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.653 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.6 t30 -61.54 -17.77 56.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.437 0.637 . . . . 0.0 111.122 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.64 13.11 58.65 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.852 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.8 m-85 -120.11 162.58 19.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.162 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.9 m -80.13 125.31 29.66 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.31 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.506 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.44 -1.083 0 CA-C-O 118.283 -1.287 . . . . 0.0 111.017 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 59.0 Cg_endo -71.76 153.8 59.07 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.947 2.431 . . . . 0.0 110.772 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -70.32 114.17 8.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.098 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 tt -150.17 156.92 6.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.386 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.4 83.73 2.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.443 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -129.51 126.13 37.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.0 mtpm? -64.41 124.26 21.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.6 p -92.99 142.93 26.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.016 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -106.0 -8.61 17.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' ' 16' ' ' ASP . 22.2 ptt180 175.57 165.69 0.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.406 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -61.29 -42.41 98.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -68.87 -5.67 22.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 37.6 t70 -91.8 -13.41 31.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.733 . . . . 0.0 109.22 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 90.7 m -89.9 143.6 30.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.995 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.98 145.6 80.18 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.749 2.299 . . . . 0.0 112.824 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.57 -126.67 42.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.991 -0.624 . . . . 0.0 111.948 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.13 22.45 15.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.697 0.284 . . . . 0.0 110.541 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.4 m -65.13 150.57 47.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.123 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.9 pt -116.88 158.26 17.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 111.51 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 t -82.36 97.31 8.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.581 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -71.19 153.22 42.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.345 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.97 -32.37 6.15 Favored Glycine 0 N--CA 1.468 0.831 0 O-C-N 123.547 0.529 . . . . 0.0 114.129 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.616 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -61.39 -19.45 61.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.402 0.62 . . . . 0.0 110.992 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 18.87 36.06 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.022 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.676 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.7 m-85 -123.8 161.42 25.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.261 0.553 . . . . 0.0 110.007 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 64.5 m -80.65 125.23 29.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.066 0 CA-C-O 118.36 -1.244 . . . . 0.0 111.156 179.432 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 45.7 t . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.62 0.248 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 88.0 Cg_endo -78.75 -145.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.762 2.308 . . . . 0.0 111.673 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 51.4 mmm-85 -110.99 118.35 35.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.52 154.91 8.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.3 mt -117.47 64.45 0.73 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.148 0.499 . . . . 0.0 111.288 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -110.24 121.54 45.51 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 111.34 4.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.526 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.5 p -87.34 150.7 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -122.66 1.9 9.48 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 166.38 158.1 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.73 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.67 -39.02 73.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.492 0.495 . . . . 0.0 111.202 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -61.77 -23.08 65.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.345 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.48 -9.46 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.833 0.825 . . . . 0.0 109.906 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.9 m -93.41 142.67 25.53 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.03 144.05 80.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.803 2.335 . . . . 0.0 112.682 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.86 -125.25 38.55 Favored Glycine 0 CA--C 1.509 -0.327 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -112.44 26.5 10.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.884 0.374 . . . . 0.0 110.054 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.6 m -63.57 148.11 49.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.775 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 30' ' ' GLY . 23.0 pt -112.18 155.45 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.308 0.575 . . . . 0.0 111.71 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.34 97.51 7.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -80.0 158.01 26.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.923 -178.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.93 3.88 Favored Glycine 0 N--CA 1.468 0.812 0 O-C-N 123.546 0.529 . . . . 0.0 114.003 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.64 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 6.2 t30 -62.41 -14.76 44.02 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.441 0.638 . . . . 0.0 110.964 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.14 74.96 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.64 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.2 m-85 -122.83 166.76 14.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.387 0.613 . . . . 0.0 110.129 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 92.6 m -78.48 126.94 31.46 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.0 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.484 ' O ' HG12 ' A' ' 22' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-O 118.256 -1.302 . . . . 0.0 110.98 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 1.6 t . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.767 0.318 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 49.5 Cg_endo -68.44 137.55 39.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.711 2.274 . . . . 0.0 110.161 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.707 ' NH1' ' HA2' ' A' ' 30' ' ' GLY . 1.2 tpp180 -76.25 119.57 20.34 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.429 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -149.77 151.79 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.985 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.67 72.88 1.57 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 3.1 tmtm? -118.58 127.48 53.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.737 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.82 123.29 19.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . 28.4 p -102.28 146.04 28.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.958 0.885 . . . . 0.0 113.303 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.5 mmp_? -114.46 -9.72 12.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.068 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 7.0 ptp85 178.64 161.07 0.65 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.1 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 -39.54 81.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.812 0.339 . . . . 0.0 110.804 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' A' ' 11' ' ' CYS . 3.5 t70 -84.89 -15.81 43.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.812 0.815 . . . . 0.0 109.285 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 40.1 m -87.8 144.39 34.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.378 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.93 143.27 59.96 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.484 2.123 . . . . 0.0 112.834 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.21 -126.57 42.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.859 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -107.17 27.62 8.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.782 0.325 . . . . 0.0 111.043 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.2 m -70.13 148.13 49.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.61 152.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.0 110.902 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -81.84 102.0 10.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.168 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 6.5 ptmt -87.78 158.89 18.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.651 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.34 -26.71 3.59 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.8 0.688 . . . . 0.0 114.058 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.645 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 7.5 t30 -61.17 -17.04 50.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.446 0.641 . . . . 0.0 110.807 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.71 69.2 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.645 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.1 m-85 -126.09 165.83 18.12 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.664 0.745 . . . . 0.0 110.385 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 98.9 m -78.43 122.85 26.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.841 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.707 ' HA2' ' NH1' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.44 -1.097 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.962 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.6 t . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.6 Cg_endo -70.39 154.96 64.81 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.126 2.55 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -66.17 96.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.491 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.49 153.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.954 0.407 . . . . 0.0 110.49 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -146.39 130.98 17.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -61.22 128.04 34.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.989 0.423 . . . . 0.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 21.5 p -92.65 142.58 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.504 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -107.13 -14.75 14.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.469 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 174.97 161.35 0.21 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.479 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -56.06 -45.64 79.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.004 0.431 . . . . 0.0 111.074 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.6 t -65.65 -17.07 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.449 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -13.69 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.656 0.741 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.0 m -88.66 143.59 32.16 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 144.33 58.21 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.797 2.331 . . . . 0.0 113.32 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.56 -128.96 48.05 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -101.23 17.5 22.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.501 0.191 . . . . 0.0 110.563 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.693 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 87.3 m -67.25 140.86 57.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -115.61 159.18 15.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.59 97.02 5.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.754 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 5.7 ptmt -77.31 156.34 31.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.957 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.24 -30.83 5.91 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 123.53 0.519 . . . . 0.0 114.142 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.651 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.9 t30 -62.01 -16.59 52.74 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.604 0.716 . . . . 0.0 110.963 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.88 22.42 46.02 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.651 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-85 -128.67 164.1 23.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.5 m -79.99 125.22 29.49 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.806 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.543 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.662 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.3 Cg_endo -71.31 146.11 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.685 2.257 . . . . 0.0 111.196 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -66.44 101.42 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.943 0.401 . . . . 0.0 110.772 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.42 152.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.45 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.12 108.1 16.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.8 tmtm? -146.06 129.69 17.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.483 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.06 131.77 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -117.26 139.81 50.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.356 0.598 . . . . 0.0 111.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -101.94 0.2 34.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 177.66 163.02 0.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.909 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -60.27 -38.04 82.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.736 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -63.72 -18.78 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.01 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.587 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 50.8 t0 -78.87 -18.52 53.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.0 m -88.44 140.96 30.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.345 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.29 145.77 30.87 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.751 2.301 . . . . 0.0 113.444 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.23 -130.5 49.03 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.52 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -97.62 16.13 21.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.994 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.3 139.72 58.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.93 154.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.887 0.375 . . . . 0.0 110.269 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -80.55 99.68 8.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -76.51 154.54 34.53 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.314 -179.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.58 -27.65 4.52 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 123.537 0.523 . . . . 0.0 114.14 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.646 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.8 t30 -62.33 -18.28 61.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.81 9.0 60.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.761 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-85 -121.27 163.14 19.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.562 0.696 . . . . 0.0 110.732 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 68.4 m -78.02 126.06 30.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.387 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.556 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.92 0 CA-C-O 118.272 -1.294 . . . . 0.0 111.161 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.405 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 49.4 t . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.613 0.244 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 48.9 Cg_endo -68.39 163.42 36.57 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.682 2.254 . . . . 0.0 111.229 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -75.54 63.61 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.189 0.519 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.85 155.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 73.12 1.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.247 0.546 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -122.35 126.1 47.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.361 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.5 mtpm? -62.66 126.62 27.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.046 0.451 . . . . 0.0 110.35 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.533 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 8.4 p -95.47 141.53 28.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.169 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.65 -13.86 22.52 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.2 ptp180 170.54 164.87 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.452 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.79 -41.11 77.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.741 0.305 . . . . 0.0 111.159 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -64.36 -21.79 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.187 0.518 . . . . 0.0 111.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 16.0 t70 -82.14 -13.34 57.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.76 0.79 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.3 m -89.54 140.8 28.32 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.0 143.1 64.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.874 2.383 . . . . 0.0 113.25 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.25 -131.54 42.0 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 113.725 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -93.32 24.86 3.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 94.9 m -77.99 143.35 37.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 30' ' ' GLY . 35.7 pt -114.16 160.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.837 0.351 . . . . 0.0 110.482 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 t -83.06 97.8 8.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.694 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 2.8 ptmm? -74.68 166.6 23.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.213 0.53 . . . . 0.0 112.266 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.45 -37.67 26.15 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.178 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.694 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -79.52 16.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.761 0.78 . . . . 0.0 112.022 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 63.33 32.99 86.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.896 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.595 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -126.48 162.63 25.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 58.3 m -82.08 121.85 27.09 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.107 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.035 -1.425 . . . . 0.0 111.149 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.718 0.294 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.05 -149.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.789 2.326 . . . . 0.0 111.958 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -90.45 102.63 15.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.25 154.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -135.67 104.5 5.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.66 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.35 125.25 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.6 mtpt -66.43 119.11 11.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -97.22 135.84 38.58 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 13.6 ptm180 -102.4 6.46 40.23 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 165.76 157.79 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.49 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.73 -33.28 72.66 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.242 0.339 . . . . 0.0 110.929 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 42.2 t0 -82.17 -9.53 59.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.779 0.799 . . . . 0.0 110.069 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 93.5 m -89.97 137.97 27.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.317 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.56 144.99 46.11 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.852 2.368 . . . . 0.0 113.261 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.86 -131.36 47.54 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.419 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.5 22.37 6.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 72.7 m -76.67 142.82 40.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.443 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -113.82 159.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.76 97.34 8.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.605 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 3.0 ptpt -75.48 153.01 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.757 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.2 -28.88 4.6 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 123.665 0.603 . . . . 0.0 114.198 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.657 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -61.41 -21.15 63.83 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.164 0.507 . . . . 0.0 111.151 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 98.28 9.96 52.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.71 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.4 m-85 -122.0 157.76 30.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.703 0.764 . . . . 0.0 110.871 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 72.7 m -77.74 126.64 31.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.461 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 23.6 mmt85 -80.71 154.21 27.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.36 135.75 55.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.971 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 t -159.89 131.11 3.87 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.53 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 45.4 Cg_endo -71.73 130.07 16.44 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.113 1.876 . . . . 0.0 109.562 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -72.29 118.91 15.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.136 0.494 . . . . 0.0 111.381 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -148.52 151.97 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.276 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.453 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 16.5 mt -93.39 75.58 4.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.976 0.417 . . . . 0.0 111.852 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.519 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 4.6 tmtm? -122.36 122.94 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 9.3 mtpp -65.83 126.2 27.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.962 0.41 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 7.6 p -100.72 139.9 35.76 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.092 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -104.09 1.37 30.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 165.96 164.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.764 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -58.99 -39.15 80.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.073 0.463 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 t -64.17 -19.27 65.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.393 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.478 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 47.8 t0 -79.84 -18.01 51.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.78 0.8 . . . . 0.0 109.431 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 76.4 m -88.8 143.17 31.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.24 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 145.82 50.33 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.869 2.379 . . . . 0.0 113.198 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.37 -130.19 50.67 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 36.9 mt-10 -101.2 26.11 7.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 69.5 m -69.34 144.17 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.5 pt -114.4 156.06 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.731 0.3 . . . . 0.0 110.513 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -79.02 105.66 10.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.9 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 57.2 mtpt -67.28 156.32 36.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.74 -32.26 47.16 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.776 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 28' ' ' TYR . 11.4 p-10 -74.89 -6.04 47.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 87.18 29.62 22.07 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.268 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 4.3 m-85 -128.32 156.45 43.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.519 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 75.9 m -74.04 127.08 31.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.9 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.931 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.973 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.545 ' HG3' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.2 128.02 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.221 -179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -82.63 133.52 35.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.3 t -157.1 134.43 6.82 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.998 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 61.2 Cg_endo -73.12 -146.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.86 2.373 . . . . 0.0 112.07 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 86.7 mmt-85 -127.84 100.35 5.9 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.96 0.41 . . . . 0.0 110.037 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -151.24 155.58 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.513 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 80.3 mt -118.7 107.98 14.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.096 0.474 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -143.57 126.62 16.41 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.3 mttt -65.67 126.9 29.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.049 0.452 . . . . 0.0 110.508 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.0 p -112.63 145.3 40.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.481 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -99.87 -1.39 37.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.393 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 6.0 ptp85 178.08 164.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.567 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.1 -40.54 94.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.995 0.426 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -65.91 -12.89 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 46.6 t0 -86.23 4.02 40.55 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.007 0.908 . . . . 0.0 109.608 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 97.4 m -111.9 138.76 21.75 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.828 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 145.64 77.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.796 2.331 . . . . 0.0 113.455 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.83 -130.96 50.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.115 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 54.3 mt-10 -100.78 19.23 17.53 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.551 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 99.1 m -65.84 141.36 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -114.12 155.62 15.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.756 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -78.72 100.0 6.88 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.75 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 1.1 ptpm? -71.01 168.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.742 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -48.62 -40.45 24.89 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -81.12 18.64 1.02 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.346 0.573 . . . . 0.0 112.221 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 64.16 35.49 92.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.756 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.75 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 4.4 m-85 -125.05 157.73 35.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.363 0.601 . . . . 0.0 110.33 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 62.8 m -81.52 116.84 21.49 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.67 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.922 0 CA-C-O 118.24 -1.311 . . . . 0.0 111.021 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.961 0.41 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.885 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 61.7 mtm180 -74.9 138.64 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.481 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.63 138.78 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.111 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 18.6 t -144.59 134.53 11.73 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.3 Cg_endo -71.37 147.42 52.71 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.724 2.283 . . . . 0.0 110.836 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -59.41 114.12 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.103 0.478 . . . . 0.0 110.987 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -146.02 159.56 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.203 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 17.0 mt -128.27 81.55 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.261 0.553 . . . . 0.0 111.021 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.4 125.78 35.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.168 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 7.3 mttm -67.14 117.42 9.15 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 p -91.06 143.88 26.24 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -106.35 -9.03 16.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.425 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 175.02 163.99 0.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.857 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -60.13 -36.03 76.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.719 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.72 -23.02 67.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.232 0.539 . . . . 0.0 110.675 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -79.41 -19.1 50.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.034 0.921 . . . . 0.0 109.307 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 88.3 m -89.89 140.9 27.82 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.596 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.52 143.03 46.03 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.541 2.161 . . . . 0.0 113.442 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 -131.4 46.55 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.505 -0.771 . . . . 0.0 113.629 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.885 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 5.7 mm-40 -89.71 20.01 4.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 84.1 m -73.21 140.01 46.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.543 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.678 HG22 HH21 ' A' ' 2' ' ' ARG . 37.4 pt -112.47 156.53 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.235 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.1 100.21 8.92 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -71.75 153.29 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.199 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.49 -33.66 17.92 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.598 0.561 . . . . 0.0 113.512 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.627 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -61.34 -21.12 63.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.851 0.834 . . . . 0.0 110.184 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 93.95 25.74 16.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.828 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.627 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 5.7 m-85 -129.26 155.71 45.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 89.1 m -72.8 125.28 27.17 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.705 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.17 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.915 0.388 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -96.05 157.93 15.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.138 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.99 133.02 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.637 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 t -164.99 132.38 2.38 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.233 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.4 Cg_endo -65.98 142.19 67.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.422 2.081 . . . . 0.0 110.132 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -75.05 63.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.464 0.65 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -98.97 153.85 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.71 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -109.83 107.34 17.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.103 0.477 . . . . 0.0 111.412 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -147.46 125.87 12.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.251 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 14.7 mtpp -67.14 131.46 45.84 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.813 0.339 . . . . 0.0 110.375 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.5 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.7 p -109.93 139.59 44.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.125 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 16.5 ptm180 -97.79 -0.83 44.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.431 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 12.2 ptm180 177.98 163.95 0.66 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.51 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -46.78 84.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.137 0.494 . . . . 0.0 110.571 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 t -64.81 -11.8 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.56 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 37.8 t0 -82.86 -1.41 51.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.819 0.819 . . . . 0.0 110.14 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.6 m -104.51 141.72 23.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.291 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.76 146.43 48.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.974 2.45 . . . . 0.0 113.596 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -132.39 51.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.238 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -96.81 19.7 12.17 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 85.1 m -69.06 139.23 54.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 pt -118.83 154.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.242 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -76.6 104.46 7.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.7 0.762 . . . . 0.0 110.258 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -78.1 156.3 30.06 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.5 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.93 -32.23 8.65 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.49 0.494 . . . . 0.0 113.931 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.69 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -62.59 -16.65 57.46 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.657 0.741 . . . . 0.0 110.941 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.62 22.27 44.04 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.69 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.5 m-85 -126.57 158.43 36.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.214 0.531 . . . . 0.0 109.779 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.1 m -77.76 120.8 23.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.56 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.443 -1.198 . . . . 0.0 111.781 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.862 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 99.7 mtt180 -64.06 140.25 58.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.784 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -80.59 134.54 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.373 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 t -153.49 128.66 4.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.13 0.49 . . . . 0.0 111.203 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.0 Cg_endo -77.04 146.89 26.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.815 2.343 . . . . 0.0 110.971 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -61.11 113.91 2.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.83 159.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.652 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.12 82.03 2.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.306 0.574 . . . . 0.0 110.074 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -130.73 128.28 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.664 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.4 mtpt -63.94 124.43 21.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.364 0.415 . . . . 0.0 110.057 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.664 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.3 p -96.81 144.88 26.36 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.981 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -106.49 -13.74 15.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.664 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 175.79 165.14 0.36 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.114 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -59.02 -38.47 79.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.874 0.369 . . . . 0.0 110.543 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -20.6 66.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.031 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.65 -15.61 48.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 109.673 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 84.6 m -90.48 140.39 26.82 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.557 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 144.41 61.26 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.518 2.145 . . . . 0.0 112.967 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.99 -130.03 50.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.862 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 53.8 mt-10 -100.18 16.38 24.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.955 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.621 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.8 m -60.45 140.9 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.102 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.453 HG22 ' NH1' ' A' ' 2' ' ' ARG . 35.7 pt -111.28 152.63 13.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.165 0.507 . . . . 0.0 111.166 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.1 96.41 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.811 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -79.31 169.11 18.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 112.449 -177.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.07 -35.59 26.31 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 116.3 1.28 . . . . 0.0 116.3 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.443 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.5 p-10 -77.7 8.8 4.01 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.995 0.897 . . . . 0.0 111.81 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.33 25.82 73.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.098 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -124.29 158.63 32.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.327 0.584 . . . . 0.0 110.254 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.5 m -80.75 122.64 27.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.876 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.811 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.955 0 CA-C-O 118.257 -1.302 . . . . 0.0 111.453 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 13.2 mmp_? -66.66 134.76 52.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.5 136.09 40.93 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.004 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -154.08 131.82 6.33 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.023 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.47 -156.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.898 2.398 . . . . 0.0 111.863 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -94.86 117.53 30.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.13 157.83 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.905 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 18.3 mt -132.43 70.96 1.46 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.384 0.611 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HE2' ' OD2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -118.39 124.92 48.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.67 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -66.78 119.08 11.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.539 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -94.18 142.92 26.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.792 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -114.01 5.32 16.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.0 ptp180 166.96 158.32 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.744 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -58.64 -38.34 77.88 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.217 0.323 . . . . 0.0 111.131 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 m -63.37 -20.14 65.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.188 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 15.5 t70 -82.53 -12.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.811 0.815 . . . . 0.0 110.19 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 68.1 m -89.98 140.25 27.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.006 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.92 146.31 47.24 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.788 2.325 . . . . 0.0 113.313 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.5 -128.59 47.32 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.305 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 54.4 mt-10 -102.99 18.17 22.32 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.774 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 72.3 m -65.94 142.71 57.78 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.8 pt -113.77 155.97 14.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.532 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.72 99.52 5.12 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.616 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 14.3 mtpp -74.21 151.62 39.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.362 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.03 -25.31 9.88 Favored Glycine 0 C--N 1.339 0.706 0 O-C-N 123.468 0.48 . . . . 0.0 113.25 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.665 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.3 t30 -61.87 -23.45 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.066 0.546 . . . . 0.0 110.752 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.43 53.46 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.665 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.3 m-85 -120.36 159.42 25.09 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.404 0.621 . . . . 0.0 110.654 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 94.5 m -73.95 131.48 41.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.485 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.616 ' HA3' ' HD2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.882 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.546 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.45 0.166 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.79 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 76.1 mtp180 -70.9 135.49 48.01 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.31 133.44 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 1.4 t -159.63 137.15 7.09 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 120.924 0.392 . . . . 0.0 111.955 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 2.8 Cg_exo -72.3 137.75 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.049 2.499 . . . . 0.0 110.376 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.4 mmt-85 -69.39 118.86 12.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.14 153.89 12.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.423 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 12.4 mt -97.45 66.96 2.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.954 0.407 . . . . 0.0 111.673 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.548 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -106.93 122.77 47.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.429 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -67.35 135.26 52.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 14.5 p -118.75 141.4 48.66 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -100.58 -11.26 20.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.906 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.9 ptp180 176.77 165.21 0.49 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.225 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -59.12 -36.71 75.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.715 0.293 . . . . 0.0 110.871 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -63.36 -24.46 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 110.548 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 33.5 t0 -78.59 -17.96 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.025 0.917 . . . . 0.0 109.972 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 74.7 m -88.4 135.94 32.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.62 143.69 63.37 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.652 2.235 . . . . 0.0 113.328 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.05 -131.75 50.33 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.112 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.79 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 46.8 mm-40 -93.96 21.13 6.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 90.7 m -72.79 141.01 48.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.338 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.05 152.81 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.998 0.428 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.2 t -80.51 95.3 6.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -75.15 156.66 35.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.882 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.55 -28.57 5.04 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.529 0.518 . . . . 0.0 114.216 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.4 t30 -63.07 -16.35 59.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.454 0.645 . . . . 0.0 110.956 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' C ' ' HD1' ' A' ' 28' ' ' TYR . . . 88.8 17.75 55.87 Favored Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.675 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.3 m-85 -127.26 158.61 36.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.671 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 91.8 m -78.8 120.39 23.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.015 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.502 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-O 118.508 -1.162 . . . . 0.0 111.952 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 121.333 0.587 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . 56.5 mtm-85 -82.73 -177.53 6.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.711 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -71.53 136.61 47.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.974 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -148.47 124.3 5.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 120.997 0.427 . . . . 0.0 111.549 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.676 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 58.7 Cg_endo -71.61 144.63 45.03 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.909 2.406 . . . . 0.0 110.826 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -66.81 102.39 0.94 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.845 0.355 . . . . 0.0 110.619 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 tt -150.41 154.66 8.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.824 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.82 111.4 21.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.11 126.12 14.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.2 112.47 5.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.575 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.6 p -87.05 151.47 23.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -127.53 6.38 6.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 164.78 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.524 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -58.94 -35.41 73.06 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 123.21 0.319 . . . . 0.0 111.252 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -64.37 -22.65 67.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 111.193 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.76 -12.34 57.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.852 0.834 . . . . 0.0 109.924 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 60.9 m -89.99 137.68 28.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.325 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.87 145.91 76.19 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.846 2.364 . . . . 0.0 112.853 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.29 -126.27 41.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.827 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 52.4 mt-10 -108.97 22.23 16.19 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.782 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 88.2 m -64.76 147.2 53.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.733 0.301 . . . . 0.0 110.433 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.474 HG22 HH22 ' A' ' 2' ' ' ARG . 37.0 pt -112.01 153.86 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 0.0 110.771 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.1 t -79.35 95.35 5.69 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 5.8 ptmt -79.89 157.49 26.93 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.501 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.53 -27.54 4.37 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.713 0.633 . . . . 0.0 114.055 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.646 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 5.2 t30 -62.58 -14.18 39.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.564 0.697 . . . . 0.0 110.891 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.14 75.51 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.3 m-85 -121.05 167.88 12.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.565 0.698 . . . . 0.0 110.329 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 96.7 m -81.98 127.71 33.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.879 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.975 0 CA-C-O 118.22 -1.322 . . . . 0.0 111.432 179.818 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.762 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 62.9 mtm180 -78.59 155.03 29.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.434 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -68.42 134.53 50.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 0.0 110.642 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -160.88 131.02 3.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.167 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 37.2 Cg_endo -65.38 153.29 78.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.913 2.409 . . . . 0.0 110.799 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.612 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -77.49 60.85 2.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -96.86 157.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 mt -123.13 105.06 9.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.21 0.528 . . . . 0.0 110.585 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -147.22 130.27 16.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.2 mttt -60.95 127.96 34.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 20.3 p -101.9 141.27 35.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -98.48 -17.67 18.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.503 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 13.9 ptp180 173.15 166.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.822 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -57.31 -39.24 75.41 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -63.88 -24.48 67.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.315 0.578 . . . . 0.0 110.683 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 14.8 t70 -81.73 -15.72 53.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.3 m -89.67 141.85 28.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.597 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.12 144.8 53.21 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.584 2.189 . . . . 0.0 113.204 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.73 -131.55 52.11 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.312 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.762 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 31.6 mt-10 -98.84 21.92 10.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.652 0.263 . . . . 0.0 111.074 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.2 m -67.68 141.36 56.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.29 153.17 14.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.063 0.459 . . . . 0.0 110.602 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.7 t -79.68 96.1 6.13 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.75 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -81.06 156.76 25.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.077 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.81 -27.25 3.16 Favored Glycine 0 N--CA 1.468 0.799 0 O-C-N 123.713 0.633 . . . . 0.0 114.458 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.715 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 2.2 t30 -62.7 -16.87 59.28 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.335 0.588 . . . . 0.0 110.878 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 89.34 13.32 61.85 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.715 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.9 m-85 -124.91 160.34 29.08 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.638 0.733 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 68.5 m -77.88 122.15 25.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.569 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.75 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.923 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.699 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.71 0.29 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -70.28 132.32 45.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -78.96 132.09 36.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.687 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.0 t -160.92 129.24 2.92 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.15 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 64.7 Cg_endo -73.56 161.12 42.92 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 111.26 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.7 mmt-85 -80.0 61.19 3.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.395 0.617 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.1 tt -94.45 155.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.731 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 mt -117.44 105.91 12.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.75 126.37 12.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 48.0 mtpt -63.75 118.94 9.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.7 p -89.17 135.76 33.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.835 0.826 . . . . 0.0 113.174 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.26 -2.17 22.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.294 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 168.64 160.55 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.653 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.11 -41.02 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.84 0.352 . . . . 0.0 110.95 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -64.62 -16.02 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.335 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.19 -17.02 47.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.928 0.871 . . . . 0.0 109.238 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 91.5 m -89.73 140.43 27.98 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.26 146.18 56.38 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.927 2.418 . . . . 0.0 113.366 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.76 -129.09 47.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.288 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 94.5 mt-10 -102.17 23.26 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.575 0.226 . . . . 0.0 110.804 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 91.4 m -68.59 140.7 55.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.68 155.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -77.57 103.35 7.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.797 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -84.1 170.3 13.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.962 -179.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.83 -34.48 29.75 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 116.333 1.293 . . . . 0.0 116.333 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 3.4 p-10 -78.47 8.59 4.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.102 0.951 . . . . 0.0 111.888 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 72.19 26.45 72.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.992 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.552 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m-85 -125.64 156.88 38.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 110.374 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 69.4 m -77.77 120.21 22.36 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.797 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.685 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.635 ' HG3' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -67.42 126.34 28.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.209 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.97 135.01 33.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.433 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.0 t -157.3 131.23 4.88 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.984 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 73.7 Cg_endo -76.17 163.26 33.04 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.719 2.279 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 6' ' ' ARG . 37.8 tpt85 -74.26 66.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.341 0.591 . . . . 0.0 110.713 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 tt -88.86 156.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 10.9 mt -121.72 64.56 0.9 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.38 124.63 52.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.526 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.93 122.59 17.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 12.9 p -96.94 138.98 33.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.491 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 15.1 ptm180 -110.28 -1.34 17.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.16 177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HG2' ' HG3' ' A' ' 12' ' ' ARG . 16.8 ptm180 172.63 157.47 0.1 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.009 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -58.2 -39.02 77.9 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 123.458 0.473 . . . . 0.0 111.085 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -62.73 -20.57 65.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.497 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.491 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 44.7 t0 -80.99 -15.29 56.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.932 0.872 . . . . 0.0 109.728 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 87.4 m -89.94 139.81 27.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.016 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.42 146.23 39.41 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.839 2.359 . . . . 0.0 113.476 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.01 -129.97 48.7 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.464 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 55.3 mt-10 -98.7 19.07 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.5 m -67.21 137.63 56.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.158 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 pt -115.83 156.14 16.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -77.03 100.96 5.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.701 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -80.23 153.85 28.28 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.338 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.39 -27.25 3.96 Favored Glycine 0 N--CA 1.468 0.781 0 O-C-N 123.546 0.529 . . . . 0.0 114.108 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.616 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.9 t30 -61.39 -20.23 62.8 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.887 0.475 . . . . 0.0 111.043 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.79 9.06 57.76 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.85 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.2 m-85 -123.95 163.45 21.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.565 0.698 . . . . 0.0 110.401 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 93.6 m -75.72 127.55 33.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.701 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.951 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.035 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.973 0.416 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.626 HH11 HG21 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -117.01 135.76 53.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -95.53 138.39 33.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.462 . . . . 0.0 111.56 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 51.9 t -151.26 134.34 8.86 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.94 -151.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.901 2.401 . . . . 0.0 112.431 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -94.61 113.4 25.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.64 156.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.8 mt -133.1 68.52 1.5 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.463 0.649 . . . . 0.0 110.745 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.38 125.24 52.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -64.11 118.32 8.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.41 136.21 33.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.028 0.918 . . . . 0.0 113.383 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -106.08 -6.12 18.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.336 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 167.03 158.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.74 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.55 -43.78 72.3 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.44 0.463 . . . . 0.0 111.166 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 m -63.0 -20.67 65.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.999 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -83.78 -10.29 58.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.848 0.832 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.4 m -92.38 143.55 27.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 143.55 43.95 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.617 2.211 . . . . 0.0 113.278 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.32 -128.55 47.5 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.605 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 36.7 mt-10 -96.9 10.0 40.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.326 0.108 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.3 m -62.65 138.64 58.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 110.364 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.626 HG21 HH11 ' A' ' 2' ' ' ARG . 31.7 pt -115.43 163.84 12.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.817 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.29 98.39 8.12 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.696 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -79.48 153.95 29.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.384 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.67 -28.12 4.98 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 123.537 0.523 . . . . 0.0 114.106 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 2.0 t30 -61.13 -20.24 62.44 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.929 0.492 . . . . 0.0 111.207 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.7 9.37 57.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.827 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.627 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.4 m-85 -123.1 165.61 16.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.511 0.672 . . . . 0.0 110.331 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.0 m -77.6 128.63 34.45 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.065 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.696 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.11 0 CA-C-O 118.171 -1.349 . . . . 0.0 111.143 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.804 0.335 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.74 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 38.8 mmt180 -69.78 139.15 53.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.685 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -80.45 134.31 35.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 t -156.05 131.11 5.25 Favored Pre-proline 0 C--N 1.319 -0.717 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.619 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 57.5 Cg_endo -71.57 152.67 59.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.681 2.254 . . . . 0.0 111.39 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -73.92 65.47 1.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.413 0.625 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 8' ' ' LEU . 10.2 tp -105.76 165.79 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.864 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 7' ' ' ILE . 54.2 mt -128.35 105.08 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.223 0.535 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.3 tmtm? -147.09 129.57 15.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.911 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -68.01 130.74 43.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 7.5 p -110.25 149.03 30.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.583 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -113.04 2.28 15.66 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 170.5 162.52 0.07 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.776 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.38 -35.31 71.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.884 0.373 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -62.21 -25.46 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.078 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 51.8 t0 -76.72 -18.97 58.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.799 0.809 . . . . 0.0 109.492 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 92.6 m -88.89 138.07 29.54 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.843 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 146.65 41.3 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.855 2.37 . . . . 0.0 113.259 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.28 -130.4 48.81 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.334 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 51.9 mt-10 -99.52 18.13 18.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.796 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.16 139.04 58.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -113.2 154.63 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.276 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -78.74 98.95 6.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -75.95 155.52 35.0 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.389 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.17 -30.95 5.82 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 123.546 0.529 . . . . 0.0 114.102 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.653 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.6 t30 -61.54 -17.77 56.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.437 0.637 . . . . 0.0 111.122 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.64 13.11 58.65 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.852 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.8 m-85 -120.11 162.58 19.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.162 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 66.9 m -80.13 125.31 29.66 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.31 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.44 -1.083 0 CA-C-O 118.283 -1.287 . . . . 0.0 111.017 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.306 0.574 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.61 147.74 50.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.1 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.559 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -81.63 139.08 35.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.109 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.1 t -158.45 131.18 4.44 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-O 121.002 0.43 . . . . 0.0 111.382 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 59.0 Cg_endo -71.76 153.8 59.07 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.947 2.431 . . . . 0.0 110.772 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -70.32 114.17 8.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.098 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 tt -150.17 156.92 6.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.386 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.4 83.73 2.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.443 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -129.51 126.13 37.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.0 mtpm? -64.41 124.26 21.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 8.6 p -92.99 142.93 26.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.016 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -106.0 -8.61 17.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' ' 16' ' ' ASP . 22.2 ptt180 175.57 165.69 0.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.406 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -61.29 -42.41 98.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -68.87 -5.67 22.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 37.6 t70 -91.8 -13.41 31.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.733 . . . . 0.0 109.22 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 90.7 m -89.9 143.6 30.29 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.995 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.98 145.6 80.18 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.749 2.299 . . . . 0.0 112.824 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.57 -126.67 42.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.991 -0.624 . . . . 0.0 111.948 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 7.1 pt-20 -109.13 22.45 15.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.697 0.284 . . . . 0.0 110.541 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 86.4 m -65.13 150.57 47.92 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.123 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.9 pt -116.88 158.26 17.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 111.51 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 t -82.36 97.31 8.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.581 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -71.19 153.22 42.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.345 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.97 -32.37 6.15 Favored Glycine 0 N--CA 1.468 0.831 0 O-C-N 123.547 0.529 . . . . 0.0 114.129 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.616 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -61.39 -19.45 61.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.402 0.62 . . . . 0.0 110.992 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 18.87 36.06 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.022 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.676 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.7 m-85 -123.8 161.42 25.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.261 0.553 . . . . 0.0 110.007 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 64.5 m -80.65 125.23 29.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.066 0 CA-C-O 118.36 -1.244 . . . . 0.0 111.156 179.432 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.0 0.429 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.565 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 1.1 mpp_? -62.67 138.56 58.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -85.12 144.21 28.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.826 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 45.7 t -159.21 135.67 6.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.373 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 88.0 Cg_endo -78.75 -145.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.762 2.308 . . . . 0.0 111.673 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 51.4 mmm-85 -110.99 118.35 35.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.52 154.91 8.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 28' ' ' TYR . 14.3 mt -117.47 64.45 0.73 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.148 0.499 . . . . 0.0 111.288 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -110.24 121.54 45.51 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 111.34 4.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.526 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.5 p -87.34 150.7 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -122.66 1.9 9.48 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 166.38 158.1 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.73 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.67 -39.02 73.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.492 0.495 . . . . 0.0 111.202 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -61.77 -23.08 65.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.345 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.48 -9.46 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.833 0.825 . . . . 0.0 109.906 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.9 m -93.41 142.67 25.53 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.03 144.05 80.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.803 2.335 . . . . 0.0 112.682 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.86 -125.25 38.55 Favored Glycine 0 CA--C 1.509 -0.327 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 2' ' ' ARG . 10.9 pt-20 -112.44 26.5 10.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.884 0.374 . . . . 0.0 110.054 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.6 m -63.57 148.11 49.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.775 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 30' ' ' GLY . 23.0 pt -112.18 155.45 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.308 0.575 . . . . 0.0 111.71 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 t -81.34 97.51 7.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -80.0 158.01 26.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.923 -178.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.93 3.88 Favored Glycine 0 N--CA 1.468 0.812 0 O-C-N 123.546 0.529 . . . . 0.0 114.003 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.64 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 6.2 t30 -62.41 -14.76 44.02 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.441 0.638 . . . . 0.0 110.964 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.14 74.96 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.64 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.2 m-85 -122.83 166.76 14.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.387 0.613 . . . . 0.0 110.129 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 92.6 m -78.48 126.94 31.46 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.0 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.484 ' O ' HG12 ' A' ' 22' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-O 118.256 -1.302 . . . . 0.0 110.98 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.551 ' NE ' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.1 126.16 27.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.296 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.26 137.63 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.218 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 1.6 t -167.76 126.22 0.99 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.767 0.318 . . . . 0.0 111.785 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 49.5 Cg_endo -68.44 137.55 39.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.711 2.274 . . . . 0.0 110.161 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.707 ' NH1' ' HA2' ' A' ' 30' ' ' GLY . 1.2 tpp180 -76.25 119.57 20.34 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.429 -178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -149.77 151.79 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.985 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.67 72.88 1.57 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 3.1 tmtm? -118.58 127.48 53.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.737 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.82 123.29 19.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . 28.4 p -102.28 146.04 28.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.958 0.885 . . . . 0.0 113.303 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' A' ' 12' ' ' ARG . 4.5 mmp_? -114.46 -9.72 12.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.068 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 7.0 ptp85 178.64 161.07 0.65 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.1 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.82 -39.54 81.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.812 0.339 . . . . 0.0 110.804 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' A' ' 11' ' ' CYS . 3.5 t70 -84.89 -15.81 43.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.812 0.815 . . . . 0.0 109.285 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 40.1 m -87.8 144.39 34.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.378 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.93 143.27 59.96 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.484 2.123 . . . . 0.0 112.834 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.21 -126.57 42.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.859 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.551 ' HB3' ' NE ' ' A' ' 2' ' ' ARG . 3.4 mt-10 -107.17 27.62 8.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.782 0.325 . . . . 0.0 111.043 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 56.2 m -70.13 148.13 49.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.61 152.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.0 110.902 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -81.84 102.0 10.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.168 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 6.5 ptmt -87.78 158.89 18.65 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.651 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.34 -26.71 3.59 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.8 0.688 . . . . 0.0 114.058 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.645 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 7.5 t30 -61.17 -17.04 50.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.446 0.641 . . . . 0.0 110.807 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.71 69.2 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.645 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 3.1 m-85 -126.09 165.83 18.12 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.664 0.745 . . . . 0.0 110.385 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 98.9 m -78.43 122.85 26.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.841 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.707 ' HA2' ' NH1' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.44 -1.097 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.962 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 140.05 55.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.026 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -85.94 134.15 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 48.6 t -145.01 124.52 6.99 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.968 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.6 Cg_endo -70.39 154.96 64.81 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.126 2.55 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -66.17 96.24 0.32 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.491 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.49 153.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.39 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.954 0.407 . . . . 0.0 110.49 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -146.39 130.98 17.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -61.22 128.04 34.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.989 0.423 . . . . 0.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 21.5 p -92.65 142.58 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.504 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -107.13 -14.75 14.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.469 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 174.97 161.35 0.21 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.479 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -56.06 -45.64 79.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.004 0.431 . . . . 0.0 111.074 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.6 t -65.65 -17.07 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.449 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -13.69 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.656 0.741 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.0 m -88.66 143.59 32.16 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 144.33 58.21 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.797 2.331 . . . . 0.0 113.32 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.56 -128.96 48.05 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 91.0 mt-10 -101.23 17.5 22.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.501 0.191 . . . . 0.0 110.563 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.693 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 87.3 m -67.25 140.86 57.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -115.61 159.18 15.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.59 97.02 5.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.754 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 5.7 ptmt -77.31 156.34 31.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.957 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.24 -30.83 5.91 Favored Glycine 0 N--CA 1.466 0.696 0 O-C-N 123.53 0.519 . . . . 0.0 114.142 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.651 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.9 t30 -62.01 -16.59 52.74 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.604 0.716 . . . . 0.0 110.963 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.88 22.42 46.02 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.651 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-85 -128.67 164.1 23.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.5 m -79.99 125.22 29.49 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.806 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.543 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.244 0.737 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.662 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.076 0.465 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 21.1 mmm180 -107.25 179.16 4.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.509 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -77.65 134.37 38.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.014 0.435 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.4 t -155.28 128.15 4.2 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 56.3 Cg_endo -71.31 146.11 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.685 2.257 . . . . 0.0 111.196 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -66.44 101.42 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.943 0.401 . . . . 0.0 110.772 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.42 152.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.45 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.12 108.1 16.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HE3' ' O ' ' A' ' 16' ' ' ASP . 2.8 tmtm? -146.06 129.69 17.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.483 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.06 131.77 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -117.26 139.81 50.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.356 0.598 . . . . 0.0 111.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -101.94 0.2 34.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 177.66 163.02 0.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.909 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -60.27 -38.04 82.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.736 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -63.72 -18.78 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.01 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.587 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 50.8 t0 -78.87 -18.52 53.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 67.0 m -88.44 140.96 30.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.345 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.29 145.77 30.87 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.751 2.301 . . . . 0.0 113.444 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.23 -130.5 49.03 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.52 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 2' ' ' ARG . 94.3 mt-10 -97.62 16.13 21.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.994 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 90.0 m -66.3 139.72 58.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.93 154.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.887 0.375 . . . . 0.0 110.269 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -80.55 99.68 8.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -76.51 154.54 34.53 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.314 -179.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.58 -27.65 4.52 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 123.537 0.523 . . . . 0.0 114.14 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.646 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.8 t30 -62.33 -18.28 61.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.81 9.0 60.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.761 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-85 -121.27 163.14 19.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.562 0.696 . . . . 0.0 110.732 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 9' ' ' LYS . 68.4 m -78.02 126.06 30.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.387 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.556 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.442 -0.92 0 CA-C-O 118.272 -1.294 . . . . 0.0 111.161 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 132.68 54.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.582 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.85 137.49 53.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.748 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.405 ' SG ' ' HA2' ' A' ' 30' ' ' GLY . 49.4 t -154.18 137.53 10.43 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 48.9 Cg_endo -68.39 163.42 36.57 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.682 2.254 . . . . 0.0 111.229 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -75.54 63.61 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.189 0.519 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -93.85 155.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 73.12 1.28 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.247 0.546 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -122.35 126.1 47.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.361 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' ' CE1' ' A' ' 28' ' ' TYR . 5.5 mtpm? -62.66 126.62 27.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.046 0.451 . . . . 0.0 110.35 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.533 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 8.4 p -95.47 141.53 28.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.169 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.65 -13.86 22.52 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 12.2 ptp180 170.54 164.87 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.452 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.79 -41.11 77.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.741 0.305 . . . . 0.0 111.159 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -64.36 -21.79 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.187 0.518 . . . . 0.0 111.039 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 16.0 t70 -82.14 -13.34 57.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.76 0.79 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 57.3 m -89.54 140.8 28.32 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.0 143.1 64.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.874 2.383 . . . . 0.0 113.25 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.25 -131.54 42.0 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 113.725 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -93.32 24.86 3.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 94.9 m -77.99 143.35 37.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 30' ' ' GLY . 35.7 pt -114.16 160.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.837 0.351 . . . . 0.0 110.482 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 t -83.06 97.8 8.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.694 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 2.8 ptmm? -74.68 166.6 23.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.213 0.53 . . . . 0.0 112.266 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.45 -37.67 26.15 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.178 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.694 ' OD1' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -79.52 16.77 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.761 0.78 . . . . 0.0 112.022 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 63.33 32.99 86.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.896 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.595 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.3 m-85 -126.48 162.63 25.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 58.3 m -82.08 121.85 27.09 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.107 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.035 -1.425 . . . . 0.0 111.149 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.894 0.378 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -67.98 146.99 53.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.29 139.19 8.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 17.1 t -144.93 136.16 12.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.859 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.05 -149.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.789 2.326 . . . . 0.0 111.958 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -90.45 102.63 15.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -150.25 154.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -135.67 104.5 5.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.66 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.35 125.25 14.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 46.6 mtpt -66.43 119.11 11.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 6.9 p -97.22 135.84 38.58 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 13.6 ptm180 -102.4 6.46 40.23 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 165.76 157.79 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.49 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.73 -33.28 72.66 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.242 0.339 . . . . 0.0 110.929 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 42.2 t0 -82.17 -9.53 59.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.779 0.799 . . . . 0.0 110.069 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 93.5 m -89.97 137.97 27.9 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.317 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.56 144.99 46.11 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.852 2.368 . . . . 0.0 113.261 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.86 -131.36 47.54 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.419 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.5 22.37 6.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 72.7 m -76.67 142.82 40.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.443 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -113.82 159.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.6 t -82.76 97.34 8.54 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.605 ' HG3' ' HB3' ' A' ' 26' ' ' ASN . 3.0 ptpt -75.48 153.01 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.757 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.2 -28.88 4.6 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 123.665 0.603 . . . . 0.0 114.198 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.657 ' ND2' ' HB2' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -61.41 -21.15 63.83 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.164 0.507 . . . . 0.0 111.151 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 10' ' ' LYS . . . 98.28 9.96 52.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.71 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.4 m-85 -122.0 157.76 30.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.703 0.764 . . . . 0.0 110.871 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 72.7 m -77.74 126.64 31.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.461 179.662 . . . . . . . . 1 1 . 1 stop_ save_